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ABSTRACT 
Katherine S. Pawelczak 
 DNA double strand breaks (DSB), particularly those induced by ionizing 
radiation (IR) are complex lesions and if not repaired, these breaks can lead to 
genomic instability, chromosomal abnormalities and cell death.  IR-induced DSB 
often have DNA termini modifications including thymine glycols, ring fragmentation, 
3' phosphoglycolates, 5' hydroxyl groups and abasic sites.  Non-homologous end 
joining (NHEJ) is a major pathway responsible for the repair of these complex breaks.  
Proteins involved in NHEJ include the Ku 70/80 heterodimer, DNA-PKcs, processing 
proteins including Artemis and DNA polymerases µ and λ, XRCC4, DNA ligase IV 
and XLF.  The precise molecular mechanism of DNA-PK activation and Artemis 
processing at the site of a DNA DSB has yet to be elucidated.  We have investigated 
the effect of DNA sequence and structure on DNA-PK activation and results suggest 
a model where the 3' strand of a DNA terminus is responsible for annealing and the 5' 
strand is involved in activation of DNA-PK.  These results demonstrate the influence 
of DNA structure and orientation on DNA-PK activation and provide a molecular 
mechanism of activation resulting from compatible termini, an essential step in 
microhomology-mediated NHEJ.  Artemis, a nuclease implicated in processing of 
DNA termini at a DSB during NHEJ, has been demonstrated to have both DNA-PK 
independent 5'-3' exonuclease activities and DNA-PK dependent endonuclease 
activity.  Evidence suggests that either the enzyme contains two different active sites 
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for each of these distinct processing activities, or the exonuclease activity is not 
intrinsic to the Artemis polypeptide.  To distinguish between these possibilities, we 
sought to determine if it was possible to biochemically separate Artemis 
endonuclease activity from exonuclease activity.  An exonuclease-free fraction of 
Artemis was obtained that retained DNA-PK dependent endonuclease activity, was 
phosphorylated by DNA-PK and reacted with an Artemis specific antibody.  These 
data demonstrate that the exonuclease activity thought to be intrinsic to Artemis can 
be biochemically separated from the Artemis endonuclease.  These results reveal 
novel mechanisms of two critical NHEJ proteins, and further enhance our 
understanding of DNA-PK and Artemis activity and their role in NHEJ. 
 
      Ronald C. Wek, Ph.D., Chair 
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1.   Background and Significance 
 
 Genetic mutations accumulating over millions of years have lead to positive 
adaptations and changes that have created the extreme diversity that is seen in the 
multitudes of organisms today.  However, in an individual’s life span, genetic change 
can be detrimental as it can lead to phenotypical alterations that negatively impact 
physiology.  Such genetic change can occur following damage to an organism’s 
DNA, creating a genetic mutation that is propogated as individual cells divide and 
pass this mutation on to daughter cells.  DNA damage that results in a heritable 
change in DNA can occur from both endogenous and exogenous sources.  DNA 
damage from endogenous sources like replication errors and oxidative source 
includes base loss, base modification, formation of abasic sites, and single-strand and 
double-strand breaks.  Damage from exongenous sources like UV light, ionizing 
radiation and a variety of chemotherapeutic agents include photo-induced DNA 
lesions, chemical base modification, single and double-strand breaks, inter-strand 
crosslinks, protein-DNA crosslinks and other DNA lesions.  This thesis focuses on 
DNA double strand breaks (DSB) and examines the regulatory system in place in the 
cell to counteract this type of damage. 
1.1.   DNA damage 
 DNA double strand breaks (DSB) have been a topic widely studied over the 
years in part because of the ability for unrepaired DSB to induce genomic instability, 
chromosomal translocation, carcinogenesis and cell death [1].  Cellular DSB can arise 
from both endogenous and exogenous sources (Figure 1).  Endogenous DSB can  
1.1.1.  DNA double strand breaks 
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Figure 1.  DNA double strand breaks (DSB).  (A) Single-strand breaks (SSB) 
arising from reactive oxygen species (ROS) that are located in close proximity to 
each other in the genome can lead to a DNA DSB.  SSB locations are indicated by red 
circles.  (B) DNA polymerase-driven attempts to replicate past a nick in the leading 
strand template of DNA can result in a DNA DSB.  Nicks are indicated by red circles 
and newly replicated DNA is indicated by red strands.  (C) Exogenous DNA 
damaging agents like ionizing radiation (IR) produce DNA DSB with a variety of end 
modifications and various forms of DNA damage around the DNA terminus.  
3 
 
occur from reactive oxygen species that create dual lesions in close proximity to each 
other.  DSB can also arise from replication fork stalling that lead to fork collapse or 
attempts to replicate past a nick in a leading strand template [2].  In addition, certain 
genomic recombination events, including V(D)J recombination, induce DSB through 
endonuclease processing [3].  Finally, endogenous DSB can result from physical 
stress that occurs during separation of chromosomes in mitosis [4].  DSB are also 
produced from a variety of exogenous DNA damaging agents, such as ionizing 
radiation (IR) and certain chemotherapeutic agents like bleomycin and camptothecin 
[5]. 
 DNA double strand breaks produced by ionizing radiation typically do not 
have blunt, unmodified termini.  Instead, DNA termini at the site of a break induced 
by IR can have a variety of DNA lesions that present as end modifications, base 
damages and base alterations.  It has been suggested that many of these DNA 
moieties can occur in a clustered region, potentially near the site of the initial break, 
and the presence of these multiple lesions could increase the mutagenesis rate that can 
arise from IR [6].   DNA modifications include thymine glycols, ring fragmentation, 
3’ phosphoglycolates, 5’ hydroxyl groups and abasic sites.  Regions of single-strand 
DNA that arise from strand breakage can occur at a DSB as well, leaving a single-
strand overhang region at the site of the break.  These diverse forms of damage and 
structure at the site of DNA DSB are likely to impact rate and overall repair of the 
DSB.  As the structural complexity found at the site of DSB increases, the ability of 
repair decreases [7].  It is becoming increasingly apparent that the assortment of 
1.1.2.  Ionizing radiation induced DNA DSB 
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secondary DNA lesions found at the site of an IR-induced break presents challenges 
for their repair.  Due to the complexities in the DNA lesions produced by IR, one 
could imagine that different enzymes or pathways would be required to process 
different types of DNA lesions found at termini towards the joining or resolution of 
DNA DSB. 
The cell has developed two major pathways that are responsible for the repair 
of DNA DSB, homology directed repair (HDR) that is based homologous 
recombination and non-homologous end joining (NHEJ).  The mechanism controlling 
the pathway choice for repair of DNA DSB in mammalian cells has not yet been 
clearly defined.  However, it is thought that NHEJ, rather than HDR, is the 
predominant pathway for repair of DSB, particularly those induced by IR and other 
exogenous agents.  A contributing factor to this hypothesis is that HDR requires a 
sister chromatid in close proximity that is used as a template in repair of the DSB and 
thus is restricted to S/G2 [8].  This mechanism has provided the nickname “error-
free” repair for HDR, as little to no loss of genetic material occurs, particularly if the 
template used is completely homologous.  Importantly, specific DNA damage may be 
retained in HDR and require further repair or processing following initial HDR.  Non-
dividing or cells not in S phase do not have a homologous donor, and as the majority 
of DNA damage from exogenous sources affects cells without a donor, NHEJ is 
thought to be responsible for the repair of most DSB caused by IR and other 
exogenous agents.  Due to its ability to repair a DSB without a homologous template, 
NHEJ has been referred to as the “error-prone” pathway, as it is able to bring together 
1.2.  Repairing DNA DSB 
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two DNA ends that potentially have little to no homology at the site of the break.  
While in theory a simple mechanism, continuing research is showing that joining of 
two non-homologous DNA ends by NHEJ is in fact a sophisticated and complex 
mechanism of DNA repair. 
NHEJ, found to be active throughout all phases of the cell cycle, is 
responsible for the joining of a DNA DSB.  The pathway is most efficient in vitro at 
processing blunt termini that require no modification at the terminus prior to ligation.  
However, NHEJ is also proficient at joining two DNA ends that have non-
homologous overhang regions, and frequently this involves the removal or addition of 
nucleotides at the site of the break [9].  Despite the term “non-homologous” end 
joining, it has been shown that there can be a greater tendency to join two broken 
ends that contain sequences with 1-4  nucleotides that are complementary [10], 
dubbed more recently as areas of microhomology.  It is suggested that to align these 
ends of DNA at regions of microhomology, processing that results in the loss or 
addition of nucleotides must occur [11-13]. 
1.2.1.  Non-homologous end joining 
There are four specific steps in NHEJ; DNA termini recognition, bridging of 
the DNA ends also known as formation of the synaptic complex, DNA end 
processing, and finally DNA ligation (Figure 2).  After a DSB occurs, the 
heterodimeric protein Ku, made up of 70 and 80 kDa subunits, binds to the end of the 
break.  Once Ku is bound, it recruits the 465 kDa DNA-PK catalytic subunit (DNA-
PKcs).  Together, these proteins make up a heterotrimeric complex called the DNA-
dependent protein kinase, or DNA-PK.  The formation of this complex may aid in  
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Figure 2.  The Non-Homologous End Joining (NHEJ) pathway.  Following a 
DNA DSB induced by IR, the heterodimeric Ku (Ku 70 and Ku 80) complex is 
recruited to the DNA terminus, binds to the DNA and recruits the DNA-dependent 
protein kinase catalytic subunit (DNA-PKcs).  DNA-PKcs forms a heterotrimeric 
complex with Ku and its serine/theonine protein kinase activity is activated once 
bound to the DNA terminus.  Autophosphorylation and phosphorylation of other 
target proteins occurs.  Artemis, in the presence of DNA-PK and ATP, becomes 
active and is able to endonucleolytically cleave DNA termini that require processing.  
Ligase IV/XRCC4/XLF complex is recruited to DNA termini and catalyze ligation of 
the DNA DSB.   
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stabilizing the two DNA ends at the site of the break, forming a synaptic complex that 
secures the two ends together [14].  The catalytic activity of DNA-PK is activated 
once bound to DNA, and this unique serine/threonine protein kinase phosphorylates 
downstream target proteins needed for completion of the pathway [15].   
As mentioned earlier, IR does not frequently produce clean blunt-end breaks, 
and in fact regularly produces a number of complex breaks that contain DNA 
discontinuities at the terminus that require processing before proper ligation can 
occur.  Artemis is the main nuclease known to process DNA termini in NHEJ, by 
degrading DNA single-strand overhangs with its 5’ exonuclease and 5’ or 3’ 
endonuclease activity [16, 17].  Cells containing defective Artemis are hypersensitive 
to radiation treatment [18].  Polymerases responsible for adding bases at the termini 
include pol β, µ, and λ.  Pol µ  is of particular interest, as its concentration is 
increased in cells after IR exposure it is found in a complex with Ku and the Ligase 
IV/XRCC4 complex [19].    
After processing of the DNA termini, DNA ligase IV is responsible for 
ligating the DSB.  Ligase IV is able to ligate double-stranded DNA that has either 
compatible overhangs or blunt-ends [20], making it the perfect ligase for a repair 
pathway that does not require homology.  DNA ligase IV is found in a complex with 
XRCC4, and the flexibility of this complex is apparent by the fact that the complex 
can ligate one strand even if the second strand can’t be ligated (perhaps because of a 
5’ OH) [21].  XLF, a recently identified protein found to be involved in NHEJ just 
recently [22] , was found to interact with Ligase IV/XRCC4 and found to be required 
for NHEJ and can complement DNA repair defects.  Even more recent evidence has 
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shown that XLF is in a complex with Ligase IV/XRCC4, and it is believed to be 
needed for stimulating the ligase activity of the complex [21]. 
1.3.  Ku 70/Ku 80 
Ku, initially discovered as an autoantigen, is one of the first proteins to bind to 
DNA at a double strand break in NHEJ [23].  Ku is extremely abundant in the cell, at 
about 400,000 molecules per cell [24].  This DNA binding protein, found 
predominantly in the nucleus, is typically found as a stable heterodimeric complex of 
70 and 86 kDa subunits [25].  Mice deficient in either Ku 70 or Ku 80 were found to 
have low levels of the remaining subunit, indicating that the heterodimer is the stable 
form found in the cell [26, 27].  Ku can also form a heterotrimeric complex with the 
469 kDa DNA-PKcs when bound to DNA, forming the ~610 kDa DNA-PK complex.  
Very recent work from the Ramsden lab suggests that Ku also has enzymatic activity, 
5’ AP lyase activity, used in NHEJ (not BER) to remove AP sites near DSB.  Overall, 
Ku has been implicated in other cellular pathways, including telomere length 
regulation, but its main role has been shown to be crucial to NHEJ-mediated DNA 
repair in eukaryotes [28].  
1.3.1.  Background 
Ku binds to specific DNA structures in a sequence independent fashion.  
Kinetic studies have shown that Ku has a high affinity for DNA termini with values 
ranging from 1.5-4.0 x 10-10 M-1, [29] and Ku can bind to double-stranded DNA 
termini that have 5’ or 3’ single-strand overhangs or blunt ends [23, 30].  Other 
studies have reported Ku interacting with a variety of other DNA structures, including 
1.3.2.  Ku and DNA binding 
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nicked DNA, circular plasmid DNA, and single-strand DNA [31].  However, due to 
more recent structural and biochemical on Ku, it is unlikely that this heterodimer can 
bind and DNA that does not have a free terminus.  DNA length also plays a crucial 
role in Ku-DNA binding.  Photocrosslinking studies have revealed that Ku 70 is 
positioned closer to the DNA terminus and Ku 80 is positioned distally to the 
terminus [32, 33].  The size and shape of these molecules requires a DNA length of 
14-18 base-pairs for successful binding of one Ku molecule [30].  Kinetic analysis 
has revealed that Ku can bind to 1-site DNA (DNA substrate able to accommodate 
one Ku molecule) in a noncooperative fashion.  Substrates long enough to bind two 
Ku molecules, however, result in positive cooperativity, with the second Ku molecule 
loading onto the DNA and forming more contacts with the first Ku molecule already 
loaded on the DNA substrate (potentially stabilizing both Ku molecules) [34].  This 
and other studies led to the hypothesis that multiple Ku molecules can bind to DNA 
in a length-dependent fashion and line up on the substrate, much like beads on a 
string, although the biological significance of this activity is unclear.   
The “beads on a string” model of multiple Ku molecules binding to a substrate 
is consistent with data showing that Ku, once bound to the end of a double strand 
break, can translocate inward along the length of DNA in an ATP-independent 
manner.  This movement is thought to coincide with the recruitment of DNA-PKcs to 
the site of the break, and is required for DNA-PK to gain access to the end of the 
DNA substrate [34].  Interestingly, discontinuities in the DNA strucuture, such as 
bulky cisplatin lesions, do not significantly diminish Ku binding capacity, but can 
inhibit translocation of Ku along the length of DNA [35].  This impairment of Ku 
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movement along the DNA was also found to inhibit LIV/XRCC4 stimulated ligation, 
presumably because without translocation of Ku along the DNA, the ligase complex 
is unable to efficiently bind to the DNA [36].  A recent study has addressed the issue 
of Ku translocating on DNA in vivo, where the DNA is coated in histones and other 
DNA binding proteins.  These large proteins could prevent the ring-like structure of 
Ku from sliding onto the end of DNA and moving along the length of it, as suggested 
by numerous in vitro experiments over the years.  Roberts and Ramsden 
demonstrated that Ku is capable of peeling away as much as 50 base-pairs of DNA 
from around the histone octamer structure at the terminus of a double strand break, 
thus allowing for DNA-PK to slide along the DNA without the need for chromatin 
remodeling [37].  
The structural features of Ku as revealed by various methods support much of 
the biochemical evidence gathered about Ku over the years.  The two Ku subunits 
have a great deal of sequence similarity and both contain regions that contribute to the 
main DNA binding domain of the heterodimer [38].  The Ku crystal structure reveals 
a ring-like shape that does not appear to undergo any major change in conformation 
after binding DNA [39].  This ring-like structure allows for Ku to slide onto the DNA 
terminus, but the shape and geometry of the molecule renders it difficult if not 
impossible to bind to and interact with DNA in the absence of a free end.  It is 
hypothesized that two turns of DNA can fit through the channel in this ring-like 
structure.  The non-specific interaction between the sugar-phosphate backbone of 
DNA and the amino acids of the Ku ring structure is supporting evidence for Ku 
1.3.3.  Ku structure 
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binding to DNA double-strand breaks in a sequence-independent manner [39].  The 
C-terminal region of Ku 80, which is too flexible for X-ray crystallography and 
missing from the heterodimer solved structure, has been examined in solution based 
structural studies.    This work has revealed a 30 amino acid flexible linker region 
with a cluster of six alpha helixes, with the final 12 amino acid residues largely 
disordered.  This region is important for interaction with DNA-PKcs, and will be 
discussed in detail later in this chapter [40, 41].   
1.4.  DNA-PK 
 DNA dependent protein kinase catalytic subunit (DNA-PKcs) is the largest 
protein kinase in the cell reported to date at 469 kDa.  Sequence analysis places 
DNA-PKcs as a member of the phosphatidylinositol-3 (PI-3) kinase-like-kinase 
(PIKK) suerpfamily (along with ATM, ATR, mTOR, SMG-1 and TRRAP).  Grouped 
together because of their similar catalytic domains, the PIKKs catalytic domains have 
significant homology with the catalytic domains of the phosphoinositide (PI-3)-
kinases.  However, the PIKKs use their catalytic domains to phosphorylate protein 
targets on serine or threonine residues rather than lipids.  DNA-PKcs, like other 
family members, has a C-terminus kinase domain that is relatively small compared to 
the rest of the polypeptide (5-10 %), and is flanked by a FAT and FAT-C domains, 
whose roles are not yet clearly understood.  The N-terminal region is not well 
conserved, but is predicted to have multiple alpha-helical HEAT repeats [42].    
1.4.1.  Background 
DNA-PKcs was identified as playing a role in NHEJ because DNA-PKcs 
binds to the site of a DSB following binding of the heterodimer protein Ku.  
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Furthermore, glioma cell lines that contain a defect in the gene encoding DNA-PKcs 
have been shown to be defective in NHEJ and are radiation sensitive [43].  This is 
supported by data showing that the binding affinity of the 465 kDa DNA-PK catalytic 
subunit (DNA-PKcs) to the site of a DNA DSB is increased 100-fold in the presence 
of Ku [44], and the serine/threonine protein kinase activity is increased at least 6-fold 
by the presence of Ku [30].  Once bound to DNA, DNA-PKcs is able to 
phosphorylate substrate proteins, preferentially targeting serines and threonines that 
are followed by a glutamine (S-T/Q) [1].  As DNA-PK kinase activity is required for 
efficient DNA end joining [45], and inhibition of the kinase by specific inhibitors 
decreases end joining [46], a large body of work has supported the idea of 
physiological importance of phosphorylation on different protein substrates by DNA-
PK.  It has also been suggested that DNA-PK kinase activity plays a role in the DNA 
damage checkpoint or apoptotic signaling pathways [47]. 
As described earlier, the working model for DNA-PK activation requires Ku 
binding to the site of a DSB, followed by recruitment of the DNA-PKcs to the 
terminus.  Once bound, these proteins form a protein complex, termed DNA-PK, 
which exists in a dynamic state on each DNA terminus of the DSB.  DNA-PK is a 
unique kinase as it is activated only upon binding to the ends of double-stranded 
DNA [47, 48].  However, one of the biggest challenges in the field is understanding 
the molecular mechanisms that drive activation of DNA-PK by DNA.  This 
dependence on DNA for activity has led to the conclusion that DNA-PK makes direct 
contact with DNA, as supported by numerous studies reviewed in [32], including a 
1.4.2.  DNA-PK structure and activation: the role of DNA 
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study showing the importance of a leucine rich region that appears to be at least 
partially responsible for the direct interaction between the kinase and the DNA [49].  
Significant structural and biochemical advances with DNA-PK are aiding our 
understanding of DNA-PK activation. 
The DNA terminus resulting from an IR-induced DSB can vary in structure, 
size, and chemistry, each of which may play an important role in DNA-PK activation.  
Like Ku, it has been shown that DNA-PK is activated by fully duplex DNA [50].  
However, hairpin structures or supercoiled plasmids result in little or no kinase 
activity.  Furthermore, DNA-PK is preferentially activated by DNA with 3’ 
pyrimidine-rich termini, but activity is severely inhibited by cisplatin-DNA adducts 
[51].  These results are attributed to the catalytic subunit of DNA-PK, as there is no 
strong evidence for sequence-bias or strand bias with Ku and DNA, nor are cisplatin 
lesions thought to inhibit Ku binding.  Interestingly, chemical modifications to DNA 
termini such as biotin and fluoroscein do not inhibit kinase activity [14, 51].  
A large amount of in vitro biochemical analysis regarding the activation of the 
catalytic subunit has previously been determined in the absence of Ku.  Such studies 
were made possible because DNA-PKcs has an affinity for DNA in vitro, specifically 
in low salt buffer, even in the absence of Ku [52].  This assay technique results in 
interesting data stating that DNA-PKcs is preferentially activated by single-strand 
DNA ends (in a Ku-independent reaction) [53].  More recently groups have 
undertaken studies with the heterotrimeric complex that is made up of Ku 70, Ku 80 
and DNA-PKcs.  This could be considered to be the more physiologically relevant 
form of studying DNA-PK, as there is no evidence that DNA-PKcs binds to or is 
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activated by DNA in the cell in the absence of Ku 70/80.  Studies from our lab 
working with the heterotrimeric complex have revealed that DNA-PK is 
preferentially activated by 3’ pyrimidine-rich sequences, and this supports the theory 
that single-strand ends of DNA may play an important role in DNA.  Furthermore, 
studies have suggested that melting of the DNA terminus to expose single-strand ends 
may be necessary for DNA-PK to bind in a stable complex with DNA and lead to 
optimal activation of the kinase [54].  Clearly, DNA terminal structure, sequence and 
chemistry have an impact on activation of DNA-PK. 
Advances in structural studies have complemented and extended our 
understanding of DNA-PK with respect to the role of DNA in activation of the 
kinase.  Electron crystallographic studies have shown an open channel in the DNA-
PKcs structure that can plausibly interact with double-stranded DNA [55].  Due to the 
enormity of the catalytic subunit (465 kDa), structural reconstructions, primarily from 
cryo EM analysis, have resulted in fairly low resolution images. These studies have 
revealed, among other things, structural data to support the theory that the catalytic 
subunit undergoes conformational changes upon binding to DNA and these changes 
play an important role in efficient NHEJ [56, 57].  More recently, higher resolution 
reconstruction (7 Å) of DNA-PKcs was achieved.  In this study, Williams et al. show 
that DNA-PK displays handedness, with a head and base region with two side 
connections that create a tunnel-like hollow channel within the protein that is the 
proposed binding site for DNA.  Docking experiments revealed that the kinase 
domain could fit in either the head or base regions, although homology docking work 
with PI3Kgamma as a model indicate that the base region is the more plausible 
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position.  Within the central opening is an alpha-helical like protrusion, a likely 
candidate for direct interaction with DNA.  The authors propose that about 1 turn of 
the dsDNA would need to enter this channel to interact with this alpha-helical region.  
Interestingly, what appears to be a smaller cavity, only large enough to fit single-
strand DNA, is located above the larger central channel [58].  A crystal structure of 
DNA-PKcs together with truncated forms of Ku 70 and Ku 80 have resulted in a 
structure of DNA-PK with the highest resolution yet accomplished, at 6.6 Å, where 
the overall shape is discernable.  This reveals that an alpha helical region of HEAT 
repeats result in a bending of the protein structure into a hollow circular structure, like 
that described by the cryo EM data discussed above.  Interestingly, these authors 
place the catalytic domain in the top portion, or head region, of this circular structure, 
and show that there is a small HEAT repeat region inside the structure that probably 
binds DNA [59].   
Previous biochemical studies have suggested that once double strand DNA is 
threaded through the kinase, it can fray to expose a certain length of single strand 
DNA.  Each of these strands can then be inserted into what are seen from the 
structural data as two cavitities [53, 55] or, alternatively, one cavity on the perimeter 
of the molecule that may be an active site and has the dimensions to accommodate 
single-strand DNA [58] (Figure 3).  It is important to point out that the higher 
resolution structural data that has been generated suggests that there is a DNA 
binding alpha-helical region within the core of the circular cavity of DNA-PK and 
this supports the model of threading of DNA through the kinase [59].  However, this 
does not rule out the possibility that after threading, DNA could be separating and 
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wrapping around the kinase to activate via interactions in another cavity in a cis or 
trans fashion.  In fact, data showing that the kinase has alpha-helical HEAT repeats 
scattered throughout the polypeptide and distributed around the structure indicates 
that the DNA could also interact in various positions on the periphery of the kinase, 
which could result in activation of DNA-PK by DNA.  These structural and 
biochemical studies indicate that DNA is in fact important for activating the kinase, 
probably through a direct interaction that involves threading of the DNA through the 
circular structure of DNA-PK.  
While the role of DNA is crucial as the name applies, protein-protein 
interactions are also necessary for DNA-PK activation and are predominantly 
provided by the Ku heterodimer.  Two regions of Ku were not observed in the crystal 
structure, the C-terminal regions (CTR) of Ku 80 and Ku 70.  Ku 80 CTR is a region 
that has historically been shown to play an important role in DNA-PK activation.  
Kinetic analysis has shown that DNA-PKcs undergoes an extreme increase in activity 
when bound to a Ku-DNA complex as compared to just DNA alone, suggesting that a 
Ku-DNA-PKcs interaction is necessary for optimal activation of the enzyme.  
Interestingly, incubating DNA-PKcs with Ku molecules missing the CTR of Ku 80 
results in significantly reduced DNA-PK kinase activity, and it has been revealed that 
only the last 12 amino acids of the region are required for an interaction with DNA-
PKcs [38, 60].  While this region is difficult to crystallize because of the extreme 
flexibility it exhibits, solution based structural studies have shown that the CTR of Ku 
1.4.3.  DNA-PK activation: the role of protein interactions 
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80 contains a long flexible linker region with a cluster of six alpha helices that ends 
with the final 12 amino acid residues classified as highly disordered [40, 41].   
Despite results revealing that the CTR of Ku 80 both physically interacts with 
DNA-PKcs and is needed for optimal kinase activity, it is still unclear if this region 
promotes activation through recruitment of DNA-PKcs to the DSB or through direct 
contact with the DNA-PKcs polypeptide to activate the kinsae.  Intial in vivo studies 
showed that DNA-PKcs does not accumulate at DNA DSB in cells that are Ku 80 
null, indicating that perhaps the CTR of Ku 80 is needed for recruitment of DNA-
PKcs to the DSB [61].  Interestingly, studies also revealed that Ku 80 CTR 
truncations result in a level of radiosensitivity in cells that is similar to that seen with 
DNA-PKcs null cells, and this Ku 80 truncation mutant phenotype is postulated to be 
from lack of recruitment of DNA-PKcs to the site of a break.  However, controversial 
and more recent in vitro and in vivo studies show that DNA-PKcs is recruited to the 
site of a DSB in the absence of the CTR of Ku 80 (but with the remaining 
heterotrimeric protein intact) [62].  These results indicate that deletion of the Ku 80 
CTR does not disrupt recruitment of DNA-PKcs to a DNA terminus.  Although 
Weterings et al. reported seeing only a 50 % decrease in kinase activation with 
mutant Ku that was missing the CTR of Ku 80, our lab has shown that DNA-PK 
kinase activity is severely inhibited by loss of the Ku 80 CTR, with kinase levels near 
background level when incubated with truncated Ku (Bennet et al., unpublished).  
This would indicate that while recruitment of DNA-PKcs to the site of DSB is not 
dependent on Ku 80 CTR, kinase activation, and therefore repair of DSB, is 
dependent on the Ku 80 CTR.  Interestingly, new structural data suggests that the Ku 
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80 CTR extends considerably from the remainder of the Ku heterodimer, and is 
attached to the core by the disordered, flexible region.  The flexibility coupled with 
the distance of the c-terminal region afforded by the 30 residue linker from the core 
suggests that region could easily recruit and then retain interaction with DNA-PKcs at 
the site of a DSB.  It is also possible that this disordered region interacts with other 
parts of the Ku molecule to induce a conformational change that could in turn activate 
the kinase.  These possibilities raise the question of whether the CTR of Ku 80 is 
responsible for DNA-PKcs recruitment, retainment, activation or potentially plays a 
role in all three of these possibilities [63].  Clearly, further studies need to be done to 
determine the exact role of Ku 80 CTR in DSB repair. 
Successful repair of a DSB requires that the two ends of the DNA are brought 
together to allow for ligation by Ligase 4/XRCC4/XLF.  Emerging data over the 
years has indicated that NHEJ proteins must bind to DNA in order to bring the two 
ends together into a synaptic complex to allow for the ligation reaction.  Ku and 
DNA-PKcs are recognized as the first proteins to bind to the site of the damage and 
may be responsible for the recruitment of other proteins in the pathway.  This leads to 
the hypothesis that this protein complex could be responsible for bringing the two 
ends of DNA together and maintaining them in a synaptic complex.  Furthermore, it 
is possible that regions of microhomology at each DNA termini play a role in 
efficient end-joining, but these ends must be held in close proximity to allow for 
ligation.  A synaptic complex formation could provide the necessary stablization that 
1.5.  Protein-protein interactions: synaptic complex of a DNA DSB 
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would keep complementary ends at each fragment within proximity to each other 
(Figure 3). 
Many studies suggest that Ku, DNA-PKcs or the heterotrimeric complex (Ku 
and DNA-PKcs) play a crucial role in synapses of DNA ends.  Atomic force 
microscopy revealed a complex of Ku and the two DNA ends of a linearized plasmid, 
suggesting that Ku holds the two termini together in a synaptic complex [64].  Data 
showing that Ku can transfer between two strands of DNA, whether they contain 
homologous or non-homologous sequence regions, also suggests that Ku is 
responsible for the juxtaposition of DNA ends [65, 66].  More recent electron 
microscopy as well as two-photon fluorescence cross-correlation spectroscopy has 
revealed that two DNA ends are in fact brought together by two DNA-PKcs 
molecules into a synaptic complex and biochemical analysis revealed that kinase 
activation occurs following synaptic formation of the complex [14, 67]. 
SAXS structural data suggests that both the DNA-PKcs and Ku play a role in 
stabilizing two DNA termini in a synaptic complex, as the Ku 80 CTR is made up of 
a dynamic arm that is significantly extended from the core of the molecule such that it 
could interact with a DNA-PKcs molecule across the synapses, and furthermore 
shows that DNA-PKcs can form head-to-head dimers [63].  The SAXS work shows 
that the dimensions coupled with the extreme flexibility of the C-terminus region of 
Ku 80 are ample enough to allow interactions with both the DNA-PKcs bound at the 
same DSB terminus, as well as across the DSB to a DNA-PKcs molecule bound to 
the opposing terminus, contacting the molecule in a trans fashion [63]. 
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Figure 3.  DNA-PK synaptic complex.  DNA threads through the ring-like structure 
of the Ku heterodimer (depicted in blue) and through a channel in DNA-PKcs 
(depicted in yellow).  Following threading of the DNA, strand separation occurs, and 
DNA-DNA, protein-DNA and protein-protein interactions may all play a role in 
bringing the two DNA-PK molecules bound to each DNA terminus into a synaptic 
complex. 
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This would suggest that the CTR of Ku 80 indeed is responsible for retaining DNA-
PKcs at the site of break, perhaps through a tethering mechanism that retains the 
kinase in a synaptic complex at the DSB site.  Recent biochemical data from our 
laboratory and structural SAXS data also suggest that the CTR of Ku 80 can form a 
dimer.  Our lab generated the 16 kDa Ku 80 C-terminus fragment indicated to be 
important for DNA-PK activation, and cross-linking data shows a homodimer being 
formed with this mutant protein.  SAXS data suggests that the Ku 80 CTR can 
interact with the remainder of the Ku polypeptide in a total of five possible different 
possible positions [63].  This Ku80 CTR homodimerization may facilitate tethering of 
the two DNA termini at a DSB to enhance synaptic complex formation and end-
joining activity (Figure 4).  These results all suggest that protein-protein interactions, 
at least in part, play a role in formation of a synaptic complex for joining of the two 
DNA termini at the site of a DSB.  The role of protein-DNA interactions in formation 
of a synaptic complex will be discussed in Chapter 3. 
As it appears that the main role of active DNA-PK is in NHEJ, considerable 
work has been done to map DNA-PK dependent phosphorylation sites of the core 
NHEJ protein machinery and uncover the in vivo relevance of these phosphorylation 
events.  Many of the original NHEJ investigators believed that DNA-PK 
phosphorylation of downstream components in the pathway was important for both 
recruitment to the DSB and subsequent activation of the key NHEJ proteins.   
1.6.  DNA-PK phosphorylation targets 
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Figure 4.  Ku 80 C-term interactions.  The Ku 80 CTR (depicted in dark blue and 
extending out from the Ku molecule) is a highly flexible region with a cluster of six 
α-helical repeats at the terminus.  Ku 80 CTR can interact with regions of the Ku 
heterodimer including itself, and this CTR-CTR interaction may promote synaptic 
complex formation.  Interactions between Ku 80 CTR and DNA-PKcs can also occur 
and may also play a role in synapsis of the DNA termini.   
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In vitro and in vivo studies of the key players revealed very few physiologically 
relevant phosphorylation sites.  Work done with XLF, a ligation stimulating factor in 
NHEJ, revealed two serine DNA-PK phosphorylation sites, but mutation of these 
residues to alanine did not appear to have any effect on DNA binding, recruitment to 
a DNA DSB, or IR sensitivity [68].  While it appears that assembly of DNA-PK on 
DNA ends plays a role in recruitment of the XRCC4-ligase 4 complex to the site of a 
DSB, no phosphorylation sites within the XRCC4-ligase 4 have been identified as 
necessary for recruitment [69].  It is possible that another DNA-PK dependent 
phosphorylation event, like autophosphorylation (further discussed below) is 
important for recruitment of the ligase complex.  Two residues were identified in 
vitro within ligase 4 as potential DNA-PK phosphorylation sites, but again, these sites 
did not have an effect on the ligase’s end-joining activity [70].  As Ku is one of the 
first proteins to bind to and make direct contact with DNA at the site of a DSB, as 
well as form a heterotrimeric complex via a direct interaction with DNA-PKcs, it is 
rational that Ku is phosphorylated by DNA-PK [38, 60].  One phosphorylation site 
was identified in the N-terminus of Ku 70 and three were identified in the C-terminus 
of Ku80, a region that is important for the kinase activity of DNA-PK [71].   
However, further analysis revealed that while these residues are phosphorylated in 
vitro, DNA-PK is not required for in vivo phosphorylation of Ku nor is 
phosphorylation of these Ku residues required for NHEJ [72].  
 Of the multiple protein substrates identified in vitro as DNA-PK 
phosphorylation targets, only two proteins within the NHEJ pathway have functional 
1.6.1.  DNA-PK autophosphorylation 
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in vivo roles upon phosphorylation by DNA-PK.  Artemis, a DNA nuclease 
implicated in end processing in the NHEJ pathway, gains endonucleolytic activity on 
DNA substrates following DNA-PK phosphorylation [73, 74].  This enzyme is 
discussed in greater detail.  The other DNA-PK dependent phosphorylation substrate 
that has been shown to shown to have in vivo relevance is DNA-PK itself.  Early 
studies with DNA-PK revealed that autophosphorylation of the kinase resulted in 
decreased kinase activity [75], and this reduction in activity was attributed to 
dissociation of the DNA-PK catalytic subunit from the Ku and DNA bound complex, 
or the “active” complex.  These studies demonstrate the dynamic complex that forms 
at a DNA DSB, and reveals a physiological role for DNA-PK autophosphorylation 
[75, 76].  Further experiments mapped the autophosphorylation sites within DNA-
PKcs and initially identified a cluster of six sites within residues 2609-2647 [77].  
Interestingly, mutational analysis of these residues revealed that autophosphorylation 
of any one of the sites alone is not necessary for NHEJ as determined by 
radiosensitivity assays.  However, when all six of the serine or threonine residues 
were mutated to alanine (dubbed the ABCDE mutant), cells displayed similar high 
levels of radiosensitivity as cells that were DNA-PKcs null [76].  When this cluster 
was mutated, repair of IR-induced DSB was reduced [78].  These studies further 
demonstrate the importance of DNA-PK autophosphorylation in vivo.  Several more 
autophosphorylation sites have been identified, and to date the ABCDE mutant and 
the PQR mutant [78, 79] are the clusters that appear to be the most biologically 
relevant.  Interestingly, each of these mutant clusters display severe radiosensitivity, 
yet the mutant DNA-PK still maintains full kinase activity and can associate with and 
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dissociate from DNA DSB.  The major defect exhibited by the two mutants described 
is a disruption in DNA end processing during NHEJ.  Further studies have shown that 
autophosphorylation at the ABCDCE sites renders DNA termini accessible for end 
processing, but not by DNA-PK dissociation.  Instead, it is proposed that following 
autophosphorylation of ABCDE, DNA-PK remains bound but undergoes a 
conformational change so that DNA ends are now made accessible to end processing 
factors and the ligase complex, and DNA-PK remains in position on the DNA termini 
to support a synaptic complex (discussed later in this chapter).  This signifies that a 
major role of DNA-PK in NHEJ involves regulation of end processing and formation 
of a synaptic complex to drive repair of the DSB [80, 81].  This model is further 
supported by recent evidence showing that autophosphorylation of DNA-PKcs occurs 
in trans, both in vitro and in vivo [82].  This indicates that a synaptic complex is 
formed, thus allowing for trans autophosphorylation between two DNA-PK 
molecules located at each termini of the DNA DSB.  Furthermore, this synaptic 
complex could protect ends from processing until autophosphorylation occurs and 
alters the complex formation, liberating ends for processing [83].  Recent in vivo 
photobleaching studies [61] and in vitro structural data support the model that 
autophosphorylation does render DNA termini accessible for processing, and this 
occurs because of a conformational change in DNA-PKcs following 
autophosphorylation.  Small angle X-ray scattering (SAXS) data revealed major 
conformational changes throughout the DNA-PKcs structure, including an opening up 
of the head and palm regions that have previously been postulated to encircle the 
DNA.  This structural change not only releases DNA termini for processing, but most 
26 
 
likely results in dissociation of DNA-PKcs from the DNA [63].  While additional 
work is needed to fully understand the mechanism of DNA-PKcs dissociation and 
clearly define the residues involved, it is clear that DNA-PK autophosphorylation 
plays two important roles, one involved in DNA termini accessibility and the other in 
dissociation.    
 Once the DNA termini have been recognized, bound, and stabilized by the 
DNA-PK heterotrimeric complex, processing of the DNA ends needs to occur to 
remove DNA discontinuities that would interfere with ligation needs to occur.  As 
mentioned earlier, DNA DSB induced by IR can be very complex, and a variety of 
DNA terminal structures can occur from one DSB to another.  Depending on the 
complexity of the DNA discontinuity, an assortment of different processing enzymes 
is required to remove DNA damage at the site of the break to allow for ligation.  It 
has also been shown that nucleotide processing (typically 1-4 NT) can occur at a 
DNA terminus to reveal regions of complementary at the DNA ends, and NHEJ can 
then proceed through annealing of these regions [84].  Enzymes implicated in DNA 
processing, include but are not limited to, FEN-1 [85], polynucleotide kinase (PNK) 
[86], Werner protein [87, 88], MRN [89], DNA polymerase µ and λ [16], and the 
nuclease Artemis [74]. 
1.7.  End processing events 
 A DSB induced by IR frequently has non-complementary ends that need to be 
joined by NHEJ, and this step can require polymerases to fill in single-strand 
overhang regions or gaps.  Of the four X family of polymerases, pol μ, DNA pol λ 
1.7.1.  Family X polymerases  
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and TdT have been implicated in NHEJ [19, 90, 91].  All have a BRCT domain in the 
N-terminus that is responsible for protein-protein interactions that aid in recognizing 
and repairing a DNA DSB, but TdT has been implicated in only playing a role in 
V(D)J initiated NHEJ, while pol μ and pol λ are thought to play a role in overall 
NHEJ [92].  Pol λ and pol μ are thought to be recruited to the site of DSB by Ku via 
an interaction with pol λ BRCT domain [93].  Pol λ was shown to preferentially fill in 
sequences at a 5’ overhang terminal structure generally in a template dependent 
fashion, thus requiring complementary ends, or regions of microhomology, at either 
end of the break [94, 95].  Like pol λ, pol μ has been indicated to play a role in DNA 
end processing during NHEJ.  However, its mechanistic role varies from pol λ, as it 
can support NHEJ of DNA ends with non-complementary sequences by initiating 
nucleotide synthesis from a 3’ overhang on one DNA using a noncomplementary 
overhang 3’ end on the opposite strand as a template [96].  Pol μ has also been shown 
to add nucleotides in a template-independent manner, with nucleotides being added at 
the terminus by terminal transferase activity [97, 98].  This polymerization step 
creates a region at the site of a break that now has microhomology that can be 
annealed and ligated together by the remaining NHEJ machinery (Ligase IV, XRCC4 
and XLF).   
 The 78 kDa nuclease, Artemis is known to be responsible for cleaving hair-
pins generated during V(D)J recombination.  More recently, Artemis has been shown 
to be play a role in NHEJ repair of IR induced DNA DSB.  The role of Artemis in 
NHEJ is based on in vivo data showing that Artemis null cells are more sensitive to 
1.7.2.  Artemis 
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IR than wild type counterparts [18].  Artemis has been found to possess 5’-3’ 
exonucleolytic activity on single-strand DNA, DNA-PK and ATP dependent 
endonuclease activity on DNA hairpin structures, and DNA-PK and ATP dependent 
endonuclease processing of 3’ and 5’ single-strand overhangs, with preferential 
cleavage at the dsDNA/ssDNA junction [74].  Artemis has also been shown to 
remove 3’ phosphoglycolate groups from DNA termini, like those generated by IR 
[99].  
Artemis is a member of the β-CASP family, a new group of the metallo-β-
lactamase fold superfamily made up of enzymes acting on nucleic acids [100, 101].  
All β-CASP family members studied to date are enzymes that process nucleic acids 
and have two major structural domains, the metallo-β-lactamase domain and the β-
CASP domain (which is embedded in the metallo-β-lactamse domain).  Artemis also 
has an extended C-terminal region following the β-CASP domain, which appears to 
be fairly disordered (unpublished PONDR data).   The metallo-β-lactamase domain is 
made up of a four-layered β-sandwich that is flanked by α-helices, with zinc 
coordination sites located in the sandwich region [102].  Artemis, as a DNA nuclease, 
hydrolyses the phosphodiester backbone of DNA, and recent work has revealed a 
histidine residue within the β-CASP domain that is critical for the catalytic activity of 
Artemis (in vitro and in vivo) [103].  Higher resolution structural data is needed for a 
greater understanding of how this enzyme is activated and regulated, but extensive 
biochemical analysis has answered some questions regarding Artemis nuclease 
activity. 
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Artemis has been shown to be phosphorylated by DNA-PK in vitro [73] and 
in vivo [104].  It has been suggested that the stimulation of endonuclease activity of 
Artemis requires binding and phosphorylation by DNA-PK which causes a 
conformational change in the C-terminal region of Artemis, resulting in relief of 
Artemis autoinihibition of the endonuclease active site [73].  DNA-PKcs-mediated 
phosphorylation of Artemis has also been suggested to be necessary for Artemis to 
retain association with DNA-PK/DNA complex at the site of the break [105].  Other 
laboratories suggested that autophosophorylation of DNA-PK results in a 
conformational change in the DNA-bound kinase which in turn alters the 
conformation of DNA such that it can be easily recognized and cleaved by Artemis 
[106, 107].  While each model differs slightly in mechanism, both models suggest 
that Artemis endonuclease activity is DNA-PK and ATP dependent.  However, many 
questions remain regarding DNA-PK dependent Artemis endonuclease activity.   
The specifics of DNA cleavage by Artemis have yet to be fully elucidated.  It 
appears that in vitro, DNA-PK dependent Artemis endonuclease activity 
preferentially cleaves single-strand overhang DNA around the SS/DS junction on 
synthetic oligonucleotide substrate.  Biochemical studies performed with DNA 
substrates containing a 21 basepair double-strand region with a 15 base 5’ single-
strand overhang result in endonuclease cleavage at the SS/DS DNA junction, 
generating a 15 base single-strand cleavage product (and a blunt double-strand 
product). Paradoxically, Lees-Miller and colleagues report that a similar substrate (25 
basepair double-strand substrate with a 15 base 5’ single-strand overhang) resulted in 
24 and 26 nucleotide excision fragments, indicating that DNA-PK dependendent 
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Artemis activity can cleave DNA at the n+1 and n-1 positions at the SS/DS junction 
[106].  3’ overhang substrates (21 basepairs of double-strand DNA with a 15 base 
single-strand overhang) are preferentially cleaved in the SS region, reducing the 15 
base overhang to a 4 to 5 single-strand overhang [74].  According to Yannone and 
Povirk, single-strand overhang length impacts the cleavage position on 3’ overhangs, 
with longer single-strand overhangs (15 base and 13 base) trimmed to leave a 5 base 
overhang while a 9 base overhang was trimmed to a 4 base overhang [99].  This 
group also observed endonuclease activity on plasmid substrates, albeit somewhat 
decreased compared to longer substrates, with 4, 5 and 6 base overhangs, resulting in 
2-4 base cleavage products.  Detailed biochemical studies with purified Artemis and 
DNA-PK further suggest that in the presence of active DNA-PK, Artemis can make 
small endonuclease cleavage products, or “trim”, DNA termini on both the 3’ and 5’ 
strand.  The authors point out that this versatile activity of Artemis would allow the 
enzyme to process a variety of DNA structures and chemistries that might exist at a 
DSB, priming the break site for polymerase-mediated extension and ultimate ligation 
of the DSB [107].  Artemis has also recently been shown to possesses DNA-PK 
dependent endonuclease activity on single-strand DNA, with a sequence preference 
favoring cleavage of thymidines [108].  Despite the details known regarding DNA-
PK dependent Artemis cleavage, further studies must be conducted to understand the 
molecular mechanism of DNA processing by Artemis. 
IR induced DNA DSB are complicated and can vary in many different ways at 
each break site, with the potential for one terminus of the DSB to have a different 
DNA structure than the opposite terminus.  As research progresses in the NHEJ field, 
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it becomes more evident that there are many proteins involved in the processing of 
this large variety of damage found at the DNA DSB.  With the variety of proteins, 
including polymerases, nucleases and kinases, it is becoming apparent that the 
processing steps are not adequately accomplished by just one protein.  Rather, it is 
likely that not every DNA DSB is processed the same way, and that only a subset of 
the processing proteins are required to repair any individual break.  It is not known 
how the correct protein needed to process a specific DNA discontinuity at the 
terminus is recruited. However, it is clear that this is a dynamic and complicated 
process that is likely to involve a variety of proteins, some of which may not yet have 
been identified. 
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2.  Materials and Methods 
Single-strand oligonucleotides were purchased from Integrated DNA Technology 
(IDT, Coralville, IA).  Oligonucleotides were synthesized with a 5’-biotin molecule 
by IDT, as indicated.  The single-strand oligonucleotides were gel-purified by 
preparative denaturing 15 % polyacrylamide gel electrophoresis.  Following 
separation by electrophoresis, oligonucleotides were visualized by UV light 
shadowing, excised from gel and eluted overnight 3 mL in elution buffer at 4ºC 
(0.3M NaOAc, 1 mM EDTA and 0.1 % SDS).  Following elution, solution was 
filtered through a sterile syringe filter to remove gel pieces.  DNA-containing solution 
was precipitated by addition of 9 mL of 100 % pure ethanol and 10 µg glycogen and 
incubated for one hour at -80ºC.  Following incubation, samples were centrifuged at 
10,000 x g for 30 minutes.  Pelleted DNA was resuspended in sterile water and DNA 
was quantified by absorbance reading at 260 nm.  DNA substrates were annealed to 
complementary oligonucleotides at a 1:1 ratio.   
2.1.  DNA effector preparation for DNA-PK kinase assays  
Oligonucleotides for Chapter 3 were annealed as follows.  The 24-bp full 
duplex DNA effector was created by annealing 3’24 to 5’24, and the 30-bp full 
duplex DNA created by annealing oligonucleotides 3’30 and 5’30.  The two Y-
shaped effectors were prepared by annealing 3’24+6 to 5’30 and 3’30 to 5’24+6.  The 
3’ overhang effector was prepared by annealing oligonucleotide 3’30 to 5’24.  To 
prepare effectors with 3’ overhangs for microhomology studies oligonucleotide 
3’24+6T, 3’24+6A or 3’24+6mix were annealed to 5’24 to make the 3’ overhang 
effectors containing homopolymeric T’s, A’s or with compatible sequences 
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respectively.  Additionally, the 3’24 oligonucleotide was annealed to 5’30 to make 
the 5’ overhang effector, and 3’24 was annealed 5’24+6T or 5’24+6A to make the 5’ 
overhang effectors for microhomology studies.  Sequences of the above DNA 
substrates can be found in Table 1.  Duplex DNA was gel-purified by native 
polyacrylamide gel electrophoresis to ensure homogeneity, eluted from gel, 
precipitated and quantified.  DNA-PK was purified from HeLa cells, and a series of 
titrations of both DNA and DNA-PK were performed to determine the appropriate 
concentrations to use in kinase assays to accurately assess binding and activation. 
Single-strand oligonucleotides from IDT were gel-purified as described 
above.  To generate 5’ radiolabeled substrates, single-strand oligonucleotides were 
incubated with T4 polynucleotide kinase (New England Biolabs), T4 PNK buffer (70 
mM Tris-HCl, 10 mM MgCl2, 5 mM Dithiothreitol) and 15 pmol of [γ-32P] ATP 
(Perkin Elmer) for 30 minutes at 37ºC.  1 nmol of ATP was added to the reaction for 
the last five minutes of incubation to ensure phosphate incorporation into every DNA 
molecule.  The reaction was stopped with the addition of 100 mM EDTA and final 
volume of reactions was brought up to 50 µL with water.  Residual [γ-32P] ATP not 
incorporated into DNA was removed by separation of reaction mix over 300 µL 
Sephadex G-50 spin columns.  Radiolabeled DNA oligonucleotides were annealed to 
complement and gel purified as described above.  To generate 3’ radiolabeled DNA 
substrates, single-strand complementary oligonucleotides were annealed and 
incubated with [α-32P] dCTP and Klenow (exo-) fragment for 30 minutes at 37ºC.  
2.2.  DNA substrate preparation for nuclease assays and mobility gel-shift 
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Reactions were stopped with the addition of 100 mM EDTA and gel purified as 
described above.   
Cell free extracts were prepared from 12 L of HeLa cells grown in DMEM 
supplemented with 10 % Fetal Bovine Serum to 1x106 cells/mL.  To prepare extracts, 
cells were pelleted at 4,000xG  for 10 minutes, washed in cold 1x PBS and repelleted.  
Pellet was resuspended in 20 mL of hypotonic buffer (10 mM Tris-HCl pH 8.0, 1 mM 
EDTA, 5 mM DTT) and incubated on ice for 20 minutes.  Protease inhibitors were 
added (0.5 mM PMSF and 1 µg/mL each leupeptin and pepstatin) and cells were 
subjected to 20 strokes of Dounce homogenization.  20 mL of high salt buffer (50 
mM Tris-HCl pH 8.0, 10 mM MgCl2, 2 mM DTT, 25 % sucrose and 50 % glycerol) 
was added 1 mL at a time while stirring extract at 4ºC.  3 mL of saturated AMS was 
added 1 mL at a time while stirring, and then sample was stirred for an additional 30 
minutes at 4ºC. The sample was sedimented at 30,000 x g for one hour at  4ºC and the 
supernatant was dialyzed overnight against 3 x 1 Liter buffer changes in 10 mM Tris-
HCl pH 7.5, 1 mM EDTA, 10 % glycerol and 1 mM DTT (Buffer A) with the 
addition of 100 mM KCl.  Following dialysis, sample was sedimented at 3,000 x g to 
remove any residual debris and applied at 3 mL/min to a 30 mL sepharose column 
with double-strand DNA conjugated to it to fractionate protein.  The column was 
washed with 50 mL of Buffer A and bound protein was eluted with Buffer A 
containing 500 mM KCl.  The 5 mL elution fractions were screened for protein using 
Bradford reagent and a DNA-PK kinase assay was done on the fractions with protein 
to ensure that they contained DNA-PK.  Fractions containing an absorbance greater 
2.3.  Protein purification of DNA-PK  
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than 50 % of the maximal absorbance and kinase activity were pooled and dialyzed 
overnight against Buffer A with 100 mM KCl.  Following dialysis, the remaining 
sample was further fractionated by chromatography at a flow-rate of 3 mL/min on a 
10 mL Heparin column.  The column was washed in Buffer A with 100 mM KCl and 
bound protein was eluted with a 50 mL linear gradient from 100 mM KCl to 0.6 mM 
KCl.  The 3 mL fractions were assayed for total protein by Bradford, DNA-PK kinase 
activity, and Ku binding activity by electrophoretic mobility shift assay (EMSA).  
Pooled fractions were dialyzed overnight against Buffer A with 100 mM KCl and 
applied to a 2 mL Q-sepharose ion exchange column at a flow-rate of 1 mL/min.  The 
column was washed with 10 mL of Buffer A-100 mM KCl and bound protein was 
eluted with a 20 mL linear gradient from 100 mM KCl to 1.0 M KCl.  The 1 mL 
fractions were assayed for total protein by Bradford and SDS-PAGE analysis, DNA-
PK kinase activity, and Ku binding activity by electrophoretic mobility shift assay 
(EMSA).  Pooled fractions were dialyzed overnight against Buffer A with 200 mM 
KCl and 20 % glycerol and aliquots were frozen at -80ºC.   
 Protein samples were separated by SDS-PAGE and either stained with 
Coomassie Blue or transferred to Immobilon-FL membranes (Millipore, Bedford, 
MA), probed and then visualized using chemiluminescent detection, and the LAS-
3000 imaging system (FujiFilm) was used to document and quantify blots.  [His]6-
Artemis was detected in immunoblots using either a monoclonal antibody against the 
N-terminal [His]6 fusion tag, anti-xpress, (Invitrogen) or a polyclonal antibody 
2.4.  SDS-PAGE and western blot analysis 
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directed against the full length of Artemis (Bethyl Laboratories, Montgomery, TX).  
DNA-PKcs was detected using a polyclonal antibody against DNA-PKcs (Abcam).   
 EMSAs were performed in 20 µL reactions containing 50 mM NaCl, 10 mM 
Tris-HCl pH 7.9, 10 mM MgCl2, 1mM DTT, 100 fmol of 5’ radiolabeled double-
strand 30mer DNA substrate (JTILH2.1/JTILH2.2, see Table 1) and 2 µL of each 
fraction from a DNA-PK prep.  Protein samples were incubated with DNA for 5 
minutes at room temperature.  Separation was performed on a 6 % non-denaturing 
polyacrylamide gel, vacuum dried and visualized using PhosphorImager analysis.  
2.5.  Electrophoretic mobility shift assays (EMSA) 
Kinase assays containing a single effector per reaction were performed at 37º 
C in a final volume of 20 µl containing 20 mM HEPES, pH 7.5, 8 mM MgCl2, 1 mM 
DTT, 5 % glycerol, 125 µM ATP, [γ-32P] ATP (0.5µCi), 6.3 nM DNA-PK, 5 nM 
DNA, and 500 µM p53 synthetic peptide.  Taking into account the buffer in which the 
DNA-PK preparations were dialyzed, the final KCl concentration of the reactions 
ranged from 20 mM to 70 mM.   In addition, to determine the effect of ionic strength, 
a series of DNA-PK activation experiments were performed at varying KCl 
concentrations and the results demonstrated no significant effect over the range of 
concentrations tested (Supplementary Data).  Biotinylated duplex DNA was 
incubated with 1 ng Streptavidin (SA) / fmol DNA and incubated on ice for 5 min.  
DNA-PK and reaction buffer containing peptide were added to DNA and incubated 
on ice for 5 min.  Reactions were initiated with addition of ATP, incubated at 37ºC 
for 15 or 30 min, as indicated, and terminated by addition of 20 µl of 30 % acetic 
2.6.  DNA-PK kinase assays 
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acid.  Reactions products were spotted on P81 phosphocellulose filter paper.  The 
paper was washed five times, 5 min. each, in 15 % acetic acid, once in 100 % 
methanol and allowed to dry.  Samples were quantified by PhosphorImager® analysis 
using ImageQuant software (Molecular Dynamics).  Each DNA effector used in the 
assays to analyze dimeric activation was bound with SA then DNA-PK was added to 
the DNA and allowed to incubate for 5 min, on ice.  Each effector was then added 
alone to a tube or mixed with the complementary pre-bound effector and allowed to 
incubate on ice for 5 min.  Reaction buffer and peptide were then added to the DNA- 
DNA-PK mix, the reaction was initiated with ATP and the assay was completed as 
described above. 
Kinase assays were performed as described above with the following 
modifications.  Reactions contained 20 nM DNA-PK and 1.0 µCi [γ-32P] ATP.  
Where indicated, reactions were performed in a time-dependent manner.  Reactions 
were terminated with addition of SDS buffer and loaded onto an 8 % SDS-PAGE gel.  
Following electrophoresis, the gel was dried and visualized by PhosphorImager® 
analysis. 
2.7.  DNA-PK autophosphorylation assay 
DNA synaptic complex formation was determined by incubating 500 fmol of 
each biotinylated DNA effector with 10 µL slurry of Streptavidin magnetic beads 
(Promega) in 500 µL of 10 mM Tris-pH 7.5, 1 mM EDTA, 5 % glycerol, and 0.1 % 
BSA for 30 minutes to allow for binding to occur.  SA-DNA magnetic beads were 
washed three times to remove excess DNA.  DNA-PK was bound to the SA- DNA as 
2.8.  DNA-PK pull down assay 
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well as to a non-biotinylated DNA effector with a [γ-32P] ATP 5' label in a 20 µl 
reaction containing 20 mM HEPES, pH 7.5, 8 mM MgCl2, 1 mM DTT, and 5 % 
glycerol.  Following a 5 minute incubation period, the DNA-PK-5' labeled DNA 
effector complex was added to the SA-DNA-DNA-PK bead mixture and allowed to 
incubate at room temperature for an additional 5 minutes.  The beads were collected 
in a magnetic separator and the supernatant was removed, beads were gently washed 
two times in reaction buffer, and the bound DNA quantified via scintillation counting. 
2.9.  Cloning and production of [His]6-Artemis 
2.9.1.  Polymerase Chain Reaction (PCR)
 The Artemis gene was amplified via PCR from a B-cell cDNA library using 
primers specifically designed to encompass the entire gene, 2220 basepairs.  PCR 
primers were synthesized by IDT with the following sequences; 
CCCAACCAGGTTATTTGAACATTTT (antisense) and 
GTCCCGGACTCTGGGATCGG (sense).  PCR reactions were performed in 20 µL 
containing 100 pmol of each primer, 500 µM dNTPS, 2 units Deep Vent DNA 
polymerase (NEB), 2 mM MgSO4 and 10 ng of cDNA.  Following initial 
denaturation for five minutes at 94ºC the reactions were subjected to 25 three-step 
cycles consisting of 30 seconds at 94ºC, 30 seconds at 62ºC and 2 minutes at 72ºC.  A 
final incubation at 72ºC. was performed to fully extend the PCR products.  The DNA 
product was separated on a 0.8 %  low-melting point agarose gel and bands were 
excised.    
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 The gel-purfied PCR product was cloned into a BLUNT-TOPO-II vector 
(Invitrogen) to create the pCR-Blunt-Artemis construct.  In-gel ligation was done by 
melting agarose plug containing PCR product at 65ºC.  5 µL of melted agarose PCR 
product was brought to final reaction mix of 20 µL with 100 ng of TOPO vector, 3 
units T4 DNA Ligase (NEB), 10 mM MgCl2 and 1 mM ATP.  This reaction was 
incubated overnight at 15ºC.  Following incubation, ligated products were 
transformed into bacteria by reheating the ligation products at 65 ºC for five minutes 
and adding 5 µL of this mix to 200 µL completent XL-1 Blue E. coli cells 
(Stratagene).  Tubes were placed on ice for 10 minutes, heat shocked at 42ºC for 2 
minutes.  Following heat shock, 1 mL of LB media was immediately added to the 
reaction tube and reactions underwent shaking at 250 rpm for 1 hour at 37ºC.  
Transformed E. coli was spread on agar plates containing 200 µg/mL Ampicillin and 
incubated overnight at 37ºC.   Colonies were selected from plates, expanded in LB 
media and plasmid DNA purified using Qiagen mini-prep spin column.  Restriction 
enzyme analysis was performed to ensure proper insertion of Artemis gene into the 
TOPO vector.  Following verification, the Artemis gene was excised from the TOPO 
vector with Xba I and was filled in with Sequenase and dNTP’s to create a blunt end 
at the XbaI site and then further digested with KpnI.  The fragment was then gel 
purified and cloned into the pRSETC vector (Invitrogen) to incorporate an N-terminal 
His6 tag.  The His6-tagged Artemis gene was excised using Xba I and Not I, and 
cloned into the pBacPAK8 vector (Clontech) to create BacPAK8-Art-His.  
Sequencing analysis verified the insert sequence. 
2.9.2.  Vector generation 
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 The BacPAK8-Art-His construct was transfected into SF9 insect cells in 
conjunction with Bsu36I-digested BacPAK6 viral DNA to generate recombinant 
baculovirus.  All baculovirus methods take place at room temperature, including 
growing of SF9 cells, unless otherwise mentioned.  Briefly, 2 mL of SF9 insect cells 
at 5x105 cells/mL in complete Grace’s insect media (Clontech) supplemented with 10 
% FBS were placed in a 35 mm tissue culture dish and allowed to adhere for one hour 
at room temperature.  Once attached, the cells were washed with PBS and placed in 2 
mL of media containing no FBS (basic media) for 30 minutes.  During this incubation 
time, 500 ng of BacPAK8-Art-His was incubated with 5 µL of pBacPAK 6 that had 
been digested Bsu36I (provided by Clontech kit) in a final volume of 96 µL.  4 µL of 
the transfection agent Bacfectin (Clontech) was added to the mix and incubated for 15 
minutes.  Basic media was removed from adherent cells and the total volume of 
transfection mixture was slowly added to the adherent cells and incubated for 5 hours.  
Following incubation, 1.5 mL of complete media was added to the dish and the plate 
was incubated for 72 hours.  After 72 hours the media, which contains viruses 
produced by the transfected cells, was removed and saved in a sterile tube. 
2.9.3.  Baculovirus production 
The supernatant removed from the cells described above contains your target 
virus, but often it will contain a mixture of other viruses as well.  To isolate 
recombinant viruses, a plaque purification assay was completed.  Serial dilutions of 
the virus were made to give final dilutions of 10-1 to 10-3.  6-well dishes with 1x106 
SF9 insect cells plated on them were infected with these dilutions.  To accomplish 
this, media was removed from the cells and 200 µL of virus dilutions were added to 
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each dish and carefully placed to incubate for one hour in a location that will not 
disturb the small amount of liquid on the plate.  4 % sterile low melting agarose was 
melted during this incubation and mixed with warm Grace’s media to generate a 1 % 
agarose solution.  Following viral incubation on cells, the inoculum was removed and 
1.5 mL of the warm agarose/media solution was added to the cells and allowed to set 
until firm.  1.5 mL of media was then added on top of the agarose layer and the cells 
were incubated for 5 days.  Following incubation, media was removed and 1 mL of 
0.03 % neutral red dye (diluted in sterile 1x PBS) was added on top of the agarose 
and allowed to soak into agarose for 1 hour.  The dye was then removed, plates were 
inverted and stored overnight in the dark to allow for plaques to “clear”.  Areas of 
cells that have died due to viral infection will appear as clear spots in red dye.  
Following clearing, plaques appeaing as clear areas were picked using glass Pasteur 
pipettes and resuspended in 1 mL of media.  Viruses were allowed to diffuse out 
overnight, and the resulting supernatant was called the plaque purified primary virus.  
This plaque purified virus can now be amplified to generate a passage one (P1) stock 
by adding it to 5x105 SF9 cells on 6-well dishes, allowing to incubate for five days 
and removing supernatant that is now the P1 virus.  To screen this virus and ensure 
that it is producing the His-Artemis gene, infected cells that P1 was removed from 
were scraped off of plates into 500 µL of 1x SDS loading buffer and western blot 
analysis was done on these samples as described above using anti-artemis to 
determine if the virus produced was accurate.  As western blot analysis revealed the 
presence of Artemis in the infected cells, the P1 was further amplified into a P2 virus 
by infecting 50 mL of SF9 cells at 5x105 cells/mL with 50 µL of P1 virus and 
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incubating for 5 days.  Cells were pelleted and supernatant was saved as P2.  A 
plaque assay was done to determine the viral titer on the P2 virus.  Briefly, plaque 
assays to titer virus are done as described above except plaques (clear spots following 
addition of red dye to plates) are counted.  The following equation is used to 
determine titers. 
Titer (pfu/mL) = (# of plaques * 5) / dilution factor 
# of plaque is multiplied by 5 because only 200 µL of a viral dilution was used in this 
assay and the equation calls for a titer in mL.   
One amplification of P2 produced 25 plaques a plate with a virus dilution of 10-5: 
(25*5) / .00001 = 1.25 x 107 pfu/ml 
Following determination of the P2, the P2 virus was amplified to create a P3.  The 
following equation is used to determine how much virus to infect cells with.  An MOI 
of 0.1 is needed to amplify virus.   
 (MOI) * (# of cells) / viral titer = ml of virus to use 
 
 100 mL of SF9 cells at 5x105 cells/mL were infected with 400 µL of P2 virus to 
generate a P3 virus.  The P3 virus was subsequently titered and a titer of 1x108 
pfu/mL was determined.   
200 mL of SF9 cells at 1x106 cells/mL were infected with P3 baculovirus at an 
MOI of 10, driving expression of the [His]6-Artemis protein for 48 hours.  Infected 
cells were sedimented at 4,000 x g at 4ºC for 15 min and washed once in PBS, 
repelleted and resuspended in buffer P50/10 (50 mM KPi, pH 7.85, 10mM KCl, 10 % 
glycerol, 5 mM imidazole).  All buffers used in protein purification were 
2.10.  Protein expression and purification of [His]6-Artemis 
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supplemented with protease inhibitors (0.5 mM PMSF and 1 µg/mL each leupeptin 
and pepstatin).  Cells were lysed by Dounce homogenization and sonication, and 
extract was sedimented at 10,000 x g at 4ºC for 30 minutes.  The supernatant was 
retrieved, and KCl was added to adjust the salt concentration to 500 mM KCl.  The 
high-salt extract was batch adsorbed to 10 mL of Phosphocellulose matrix 
equilibrated in buffer P50/500 (50 mM KPi, pH 7.85, 500 mM KCl, 10 % glycerol, 5 
mM imidazole).  The matrix and cell extract slurry was applied to a 30 mL syringe 
with a frit at the bottom of it and the flow-through was collected and immediately 
applied at a flow rate of 0.3 mL/min to a 2 mL Nickel-agarose column equilibrated in 
the same buffer.  The flow-through material was re-applied and the column 
subsequently washed with 20 mL buffer P50/500 followed by a 20 mL wash with 
P50/10.  Bound protein was eluted in P50/10 with 200 mM imidazole.  The 0.5 mL 
fractions were collected and screened for protein using Bradford reagent.  Fractions 
containing an absorbance greater than 50 % of the maximal absorbance were pooled 
and dialyzed overnight against buffer P10/200 (10 mM KPi, pH 7.85, 200 mM KCl, 
10 % glycerol, 2 mM DTT).  A portion of protein pooled from the Nickel-agarose 
column was dialyzed overnight against Buffer A (50 mM Tris, pH 7.5, 200 mM KCl, 
20 % glycerol, 1 mM DTT), aliquoted and stored directly at -80º C.  Following 
dialysis, the remaining sample was further fractionated by chromatography at a flow-
rate of 1 mL/min on a 5mL CHT-Hydroxyapatite (HAP) column (Biorad) 
equilibrated in buffer P10/200.  The column was washed with buffer P10/200 and 
bound protein was eluted with a 25 mL linear gradient from 10 mM KPi to 500 mM 
KPi.  All of the 1 mL fractions were assayed for total protein and screened for 
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exonuclease activity.  Pooled fractions were dialyzed overnight against Buffer A and 
frozen at -80º C.   
 To assay phosphorylation status of Artemis by DNA-PK, kinase assays were 
performed at 37ºC in a final volume of 20 µL containing 50 mM HEPES, pH 7.5, 100 
mM KCl, 10 mM MgCl2, 0.2 mM EGTA, 0.1 mM EDTA, 1 mM DTT, 125 µM ATP, 
[γ-32P]-ATP (1.0 µCi), 100 nM 30-bp full duplex DNA, 60 nM DNA-PK and varying 
concentrations of [His6]-Artemis, as indicated.  DNA-PK was added to buffer and 
DNA and incubated on ice for 5 minutes, followed by addition of Artemis.  Reactions 
were initiated with the addition of ATP, incubated at 37ºC for 30 minutes, and 
terminated by addition of SDS loading dye.  Reactions were heated at 95ºC for 5 
minutes and separated by SDS-PAGE.  Gels were dried and phosphorylated products 
were visualized by PhosphorImager analysis. 
2.11.  DNA-PK phosphorylation of Artemis 
The 5’ radiolabeled DNA substrate 
(CCCCTATCCTTTCCGCGTCCTTACTTCCCC) used for single-strand nuclease 
assays was radiolabeled as described above with [γ-32P] ATP [51].  To generate the 3’ 
radiolabeled DNA substrate for single-strand nuclease assays, complementary 
oligonucleotide were annealed, extended and labeled with [α-32P] dCTP and Klenow 
(exo-) fragment.  The extension reactions were performed for 30 minutes at 37ºC, 
followed by a chase reaction containing 1mM dCTP to ensure full extension.  The 
DNA was denatured at 95ºC in formamide buffer and separated on a 12 % 
polyacrylamide/urea denaturing gel.  The radiolabeled band was visualized using 
2.12.  In vitro exonuclease assays 
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film, excised, eluted from the gel piece as described above, ethanol precipitated and 
resuspended in water.  Single-strand nuclease assays were carried out in a final 
volume of 15 µL in nuclease buffer (25 mM Tris, pH 8.0, 10 mM KCl, 10 mM 
MgCl2, 1 mM DTT) with 50 fmol of radiolabeled DNA and varying amounts of 
Artemis (as indicated) at 37ºC for 30 minutes.  Reactions were terminated by the 
addition of formamide loading dye, heated at 95ºC for 5 min, loaded onto a 12 % 
polyacrylamide/urea denaturing gel, and products were visualized by PhoshorImager 
analysis.   
The 5’ radiolabeled hairpin substrate with a 6 base single-strand overhang and 
the 3’ overhang DNA substrates were prepared as described above (2.2), as was the 3’ 
radiolabeled substrate with a 5’ single-strand overhang.  Endonuclease assays were 
carried out in a final volume of 10 µL containing nuclease buffer with 50ng/ul of 
BSA, varying amounts of Artemis, 50 nM of DNA-PK, 250 fmol of radiolabeled 
DNA and 250 µM ATP (unless otherwise indicated).  Reactions were incubated, 
terminated and visualized as described above for single-strand nuclease assays. 
2.13.  In vitro endonuclease assays 
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Name Sequence Notes 
 Complementary 
to 2.2 
General DNA substrates 
JT ILH 2.1 CCCCTATCCTTTCCGCGTCCTTACTTCCCC Used as general 
double-strand 
30-mer 
substrate 
JT ILH 2.2 GGGGAAGTAAGGACGCGGAAAGGATAGGGG  
   
  Effectors for DNA-PK 
3’24 Biotin-TAGATGGACTATCGCAGCACTGTA  
3’30 Biotin-TAGATGGACTATCGCAGCACTGTACGGCTT  
3’24+6 Biotin-TAGATGGACTATCGCAGCACTGTAGCCGAA  
3’24+6A Biotin- 
TAGATGGACTATCGCAGCACTGTAAAAAAA 
 
3’24+6T Biotin-TAGATGGACTATCGCAGCACTGTATTTTTT  
3’24+6-mix Biotin-TAGATGGACTATCGCAGCACTGTAAAGCCG  
5’24 TACAGTGCTGCGATAGTCCATCTA  
5’30 AAGCCGTACAGTGCTGCGATAGTCCATCTA  
5’24+6 TTCGGCTACAGTGCTGCGATAGTCCATCTA  
5’24+6A AAAAAATACAGTGCTGCGATAGTCCATCTA  
5’24+6A TTTTTTTACAGTGCTGCGATAGTCCATCTA  
   
  DNA substrates for Artemis 
KSP 2.0 GTCCCGGACTCTGGGATCGG Artemis sense 
primer 
KSP 2.1 CCCAACCAGGTTATTTGAACATTTT Artemis 
antisense 
primer 
KSP 10.1 TTTTTGATTACTACGGTAGTAGCTACGTAGCTACT
ACCGTAGTAAT 
Art hairpin 
substrate 
KSP 10.2 ACTGAGTCCTACAGAAGGATCTTTTTTTTTTTTTT
T 
Anneal to KSP 
10.2C 
KSP 10.2C GATCCTTCTGTAGGACTCAGT Makes 3’ 
overhang Art 
substrate 
KSP 11.1 TTTTTTTTTTTTTTTAAGCTTGCATGCCTGCAGGTC
GAC 
anneal to KSP 
11.0C 
KSP 11.0C GGTCGACCTGCAGGCATGCAAGCTT Makes 5’ 
overhang art 
substrate 
KSP 11.2 AAAAAAAAAAAAAAAAAGCTTGCATGCCTGCAG
GTCGAC 
aneal to KSP 
11.0C 
KSP 11.3 GTAGATGGACTATCGCAGCACTGTA anneal to 5’30 
and for Art 5’ 
overhang 
substrate 
 
Table 1.  Oligonucleotide sequences.  All sequences are 5′-3′ with biotin 
modifications as indicated. 
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3.  Influence of DNA sequence and strand structure on DNA-PK activation 
While it is known that activation of DNA-PK is an important step in NHEJ 
[43], the exact molecular mechanism of DNA-PK activation remains to be elucidated.  
It is known that to be activated, the protein kinase must bind DNA, and structural 
studies have observed a channel in the DNA-PK catalytic subunit large enough to 
accommodate double strand DNA [58].  This suggests that DNA threads through a 
channel in the DNA-PK complex.  After the DNA-DNA-PK complex is formed, a 
DNA-PK dimer is formed, creating a synaptic complex that results in the two DNA 
termini to be joined being brought into close proximity [109].  This complex most 
likely initiates the recruitment of other NHEJ proteins and ultimate ligation of the 
DNA.   
3.1.  Introduction 
Biochemical studies suggest that melting of the DNA terminus to form single-
strand ends is needed for a stable DNA-PK-DNA complex to be formed [54].  This 
information can be used to extend the model that strand separation occurs, and the 
resulting single-strand termini can be inserted into one or more active sites on the 
kinase after synapsis of the two DNA-PK bound termini has occurred [14].   
To determine the underlying mechanism of activation of DNA-PK, we 
reported that the activation of DNA-PK is influenced by the strand orientation and 
specific base composition of a double strand DNA effector, with 3’ pyrimidine/5’ 
purine –rich termini (Figure 5) resulting in a greater level of DNA-PK activation than 
DNA effectors with 3’ purine/5’pyrimidine –rich termini [51].  A study published 
shortly after showed that DNA sequence 
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Figure 5.  Effect of DNA strand orientation and sequence bias on DNA-PK 
activation.  30mers containing 15 homopolymeric bases of 3'-dT or 3'-dA and a 
control 30mer of mixed sequence were assayed for DNA-PK activation.  Reactions 
contained 20 nM DNA-PKcs, 3.3 nM Ku and 5 nM SA – DNA, as indicated. Results 
are presented as the pmol of 32P transferred to the synthetic p53 peptide in a 30 min 
reaction. Reactions were performed in triplicate and the mean and standard error of 
the mean are presented. 
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strongly influences joining of blunt end DNA substrates via NHEJ [9].  This data 
confirmed our findings, and clearly demonstrates the importance of analyzing how 
DNA sequence composition affects the activation of DNA-PK.   
We have continued our studies of DNA-PK activation by designing DNA 
effectors that address how sequence, orientation and structure influence activation of 
DNA-PK, and these results are presented in this chapter.  Our experiments also 
indicate that using DNA effectors with compatible termini resulted in increased 
activity compared to effectors with non-compatible termini.  A strand orientation 
preference was observed in these reactions and a model based on these results is 
presented.  These results demonstrate the influence of DNA structure and orientation 
on DNA-PK activation and provide a molecular mechanism of activation resulting 
from compatible termini, an essential step in microhomology-mediated NHEJ.   
 Endogenous human DNA-PK was purified from 12 Liters of Hela cells as 
described in Materials and Methods.  Briefly, extracts were fractionated on a 50 mL 
cisplatin-damaged double-strand DNA-Sepharose column, heparin-Sepharose column 
and Q-Sepharose column.  DNA-PK containing fractions were identified by protein 
concentration as determined by Bradford assay, DNA-PK kinase activity, Ku-binding 
activity and Coomassie staining of SDS gels.  DNA-PK kinase activity was 
determined as described in Materials and Methods.  Briefly, fractions were incubated 
with a double-strand DNA substrate (ie, the effector) as it has been shown that 
double-strand DNA activates this unique kinase, as well as with a synthetic peptide 
that contains an embedded serine residue that DNA-PK will phosphorylate.  
3.2.  Results 
50 
 
Reactions were initiated with [γ-32P] ATP, incubated and spotted on P81 paper, and 
results are presented as pmol of phosphate transferred to the synthetic peptide.  Ku 
binding activity was determined as described in Materials and Methods, with 
fractions incubated with 32P-labeled double-stranded 30 base-pair DNA and separated 
on a native polyacrylamide gel.  A representative Coomassie stained 8 % SDS gel 
from a single prep is shown in Figure 6, and shows that the DNA-PK heterotrimer 
(DNA-PKcs, 465 kDa and Ku 70 kDa and 80 kDa) is purified to greater than 90 % 
homogeneity.  This is considered highly purified, as the heterotrimeric complex is not 
tagged or over-expressed. 
 Previous data revealed that DNA-PK is differentially activated by 3’ 
pyrimidine and 5’ purine-rich DNA termini, indicating that one DNA strand might be 
more important for activation than another.  Therefore, we designed a set of DNA 
effectors to determine how each strand of DNA plays a role in activation of the 
kinase.  Single-strand oligonucleotides were synthesized, gel purified and annealed to 
generate double-strand DNA effectors for use in DNA-PK kinase assays.  DNA 
effectors were designed with one strand containing a biotin molecule on the 5’ 
terminus, so that when incubated with Streptavidin, only one DNA termini was 
accessible for DNA-PK binding (Figure 7).  This in vitro design allowed us to 
manipulate DNA structure, sequence and chemistry at the DNA-PK/DNA interaction 
site so as to better understand how specific DNA effectors influenced activation of 
DNA-PK.  DNA effectors were designed with 3’ or 5’ single-strand 6-base overhang 
structures or Y-shaped 6-base termini on the accessible terminus, or as full duplexes 
(Figure 7).  Full sequences can be found in Table 1. 
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Figure 6.  SDS-PAGE of a DNA-PK protein preparation.  DNA-PK was purified 
as described in Materials and Methods:  Equal volumes of the whole cell extract 
(WCE) and elution pools from each chromatography column used to fractionate 
DNA-PK were separated on an 8 % SDS – PAGE gel and stained with Coomassie 
Blue.  The position and molecular weights (kDa) of the standards are indicated on the 
left-hand side and Ku 70, Ku 80 and DNA-PKcs are indicated on the right side. 
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Figure 7.  DNA effectors used to study DNA-PK activation.  Duplex DNA 
effectors were prepared from gel purified single strand oligonucleotides.  The 
addition of streptavidin, as indicated by the oval, results in blocking of the 5’ 
biotinylated terminus, indicated by the B.  The effectors generated have a 3’ 
overhang, 5’ overhang or Y-shaped structure at the DNA-PK accessible terminus.   
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Previous work with DNA-PKcs that has been purified free from Ku and is in a 
monomeric form showed an increase in kinase activity with DNA effectors that 
contained single-strand overhangs as compared to full duplex effectors [53].  
Importantly, it has been shown in vivo that Ku recruits DNA-PKcs to the site of a 
DNA DSB [61].  This illustrates the necessity of studying how the holoenzyme (Ku 
and DNA-PKcs) interacts with different DNA terminal structures, and so our 
experiments contain the heterotrimeric complex as opposed to DNA-PKcs alone.  The 
DNA effectors described above were incubated with DNA-PK and all experiments 
shown included a 30 base-pair DNA control to ensure that difference seen between 
DNA effectors was with varying termini was not a result of experimental variation.  
Results show that although DNA-PK is activated by a 24 base-pair duplex effector, a 
30 base-pair duplex effector results in more activity (Figure 8, bars 1 and 4).  This 
was not surprising, as previous work has shown that DNA-PK activity is length 
dependent, with longer DNA effectors resulting in greater kinase activity [35, 53].  
DNA-PK kinase activity resulting from 24 base-pair DNA effectors with an 
additional 6 base single strand overhang on the 3’ or 5’ end was no greater than that 
seen from a full 24 base-pair duplex effector (Figure 8, bars 1, 2, 3).  Interestingly, 
activity from these effectors was actually decreased as compared to the 24 base-pair 
duplex effector.  These results differ from the published results showing that DNA-
PKcs is stimulated by single-strand overhangs effectors compared to full duplex DNA 
[53], and this indicates that in the presence of Ku, DNA-PKcs does not require DNA 
with a single-strand overhang for maximal activation.   
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To further examine the inhibition in kinase activity resulting from single-
strand DNA overhangs, effectors were designed with 24 base-pairs of duplex DNA 
with an additional 6 bases of noncomplementary sequence on each strand at the 
terminus (Y-shaped effectors).  Analysis of kinase activation revealed that maximal 
DNA-PK activation was completely restored (to the level of activity seen from a 30 
base-pair duplex DNA effector) with these Y-shaped effectors, as compared to DNA 
effectors with a single-strand overhang on either terminus (Figure 8A, bar 5 
compared to bars 2 and 3).  These results suggest that single-stranded ends are not 
inhibitory to kinase activation.  In an effort to rule out any potential differences in 
DNA-PK activation resulting from sequence or orientation dependent activation, 
effectors with the identical Y-shaped structure but varied DNA sequence on each 
strand were designed.  These results again demonstrated that DNA-PK activation by 
the Y-shaped DNA effectors is comparable to the full duplex DNA effectors and 
furthermore, that any minor differences can be attributed to strand orientation-
dependent sequence bias (data not shown).  Finally, 24 base-pairs of duplex DNA 
with homopolymeric 6-base Y-shaped termini or full duplex ends were designed.  
Results show again that DNA-PK kinase activity is not increased from Y-shaped 
effectors compared to full duplex DNA effectors of identical length (Figure 8B).  
These results all demonstrate that in the presence of Ku, DNA-PKcs does not require 
single-strand termini for maximal activation. 
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Figure 8.  Effect of DNA overhangs on DNA-PK activation. DNA-PK kinase 
assays were conducted with annealed DNA effectors, as described in ‘Materials and 
methods’ section. Briefly, 24- and 30-bp full duplex DNA effectors, 3' and 5' 6-bp 
overhang effectors and Y-shaped effectors were assayed. Reactions contained 6.3 nM 
DNA-PK and 5 nM SA-DNA, as indicated. Results are presented as the picomoles of 
32P transferred to the synthetic p53 peptide in a 30-min reaction. Reactions were 
performed in triplicate and the mean and standard deviation are presented. 
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Figure 8 indicates that DNA-PK is not preferentially activated by DNA that 
contains single-strand overhang structures as compared to full duplex DNA effectors 
of the same length.  In fact, activity from single-strand overhangs is somewhat 
reduced compared to full duplex DNA.  Furthermore, a difference in activation 
between the 3’ and 5’ overhang effectors was observed.  Statistical analysis of the 
results presented in Figure 8A revealed a statistically significant difference (a P-value 
< .05) in comparisons with each set of effectors.  Despite the convincing statistical 
analysis, we decided to further investigate the small but significant differences 
observed between the single-strand overhang effectors.  We hypothesized that if there 
were truly relevant differences in activation with the varying overhang effectors, 
these differences would be emphasized as a function of DNA concentration.  In the 
standard kinase assays conducted, like that depicted in Figure 5, the DNA 
concentration (5 nM) is saturating, and so a DNA titration was conducted with each 
DNA effector to accentuate differences in the resulting kinase activity.  DNA-PK 
kinase activity was assayed with increasing concentrations of 3’ and 5’ overhang 
effectors, and a substantial difference in activity over the entire range of effector 
concentrations was observed (Figure 9).  These results confirm that DNA-PK exhibits 
lower activity from a 3’ overhang DNA effector compared to the 5’ overhang 
effector.  
Previous studies have suggested that DNA-PK activity is modulated by 
autophosphorylation.  Upon autophosphorylation, the kinase is believed to dissociate 
from the DNA effector, thus lowering overall kinase activity of DNA-PK [75]. 
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Figure 9.  Titration of DNA effectors containing 3' and 5' overhangs. DNA 
effectors with a 3' or 5' 6-base overhangs were pre-bound with excess streptavidin and 
then assayed for DNA-PK kinase activation as described in Figure 8. Reactions were 
incubated with increasing concentrations of each effector. Results are presented as the 
picomoles of 32P transferred to the synthetic p53 peptide in a 30-min reaction. 
Reactions were performed in triplicate and the mean and standard deviation are 
presented. 
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To investigate if the level of DNA-PK autophosphorylation was responsible for the 
differential peptide phosphorylation observed between 3’ and 5’ overhang effectors, 
autophosphorylation kinase assays were performed as described in Materials and 
Methods.  With autophosphorylation assays, DNA-PK itself serves as the protein 
substrate, and levels of 32P-labeled DNA-PK are visualized with a PhosphoImager 
following separation on a SDS denaturing gel.  Effectors tested had 3’ or 5’ single-
strand overhangs, Y-shaped termini or blunt termini that were all accessible for DNA-
PK binding, with the other termini blocked by streptavidin.  Results show that DNA-
PK autophosphorylation resulting from the 3’ and 5’ overhang effectors was 
significantly reduced when compared with the full duplex 30 base-pair effector 
(Figure 10).  Furthermore, the kinetics of autophosphorylation of DNA-PK was 
determined with the 30 base-pair duplex effector and the 3’ overhang effector (Figure 
11A).  The results confirm the decreased autophosphorylation obtained with the 3’ 
overhang effector compared to the full duplex DNA (Figure 10).  Quantitation of 
these results shows a time dependent autophosphorylation activity (Figure 11B).  The 
level of autophosphorylation presented in Figures 10 and 11 comparing the overhang 
effectors and the 30 base-pair duplex effector mimics the level of peptide 
phosphorylation observed in peptide-based kinase assays (Figure 8A).  Interestingly, 
the level of autophosphorylation resulting from the 24 base-pair effector is the same 
as that from the 30 base-pair effector (Figure 10, lanes 1 and 4).  When measuring 
peptide phosphorylation by DNA-PK, levels from a 24 base-pair effector are 
significantly lower than from a 30 base-pair effector (Figure 8, lanes 1 and 4).   
59 
 
 
 
Figure 10.  Autophosphorylation of DNA-PK by full duplex, overhang and Y-
shaped effectors. DNA-PK autophosphorylation was measured with 24- and 30-bp 
full duplex DNA effectors, 3' and 5' overhang effectors and Y-shaped effectors. 
Reactions were performed as described in Figure 8, initiated with 1.0 µCi [ -32P] 
ATP, and stopped with SDS. Reaction products were separated by 8 % SDS – PAGE. 
The gel was dried and exposed to a PhosphorImager. 
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Figure 11.  Time dependent autophosphorylation of DNA-PKcs by full duplex or 
3’ overhang effectors.  (A) Reactions were performed as described in Figure 10 and 
stopped with SDS at 5, 15, 30 and 45 minutes.  Reactions products were separated by 
8 % SDS-PAGE and the gel was dried and exposed to a PhosphorImager.  (B) Time-
dependent autophosphorylation of DNA-PKcs was quantified using a 
Phosphorimager and results are presented as cpm of 32P transferred to DNA-PKcs as 
time increases.   
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This is an expected result, as DNA-PK activity has been shown to be length 
dependent, with longer DNA effectors resulting in greater activity.  If DNA-PK 
autophosphorylation resulting from the full duplex sets of DNA were mimicking the 
peptide phosphorylation observed in the kinase assays, we would expect to see less 
autophosphorylation from the 24 base pair effector than from the 30-mer.  
Importantly, there is no difference in autophosphorylation between the 3’ overhang 
and 5’ overhang DNA effectors.  These results demonstrate that the reduced activity 
resulting from the 3’ overhang compared to the 5’ overhang effector is not due to a 
disparity in autophosphorylation.  However, the increase in autophosphorylation 
resulting from the 24 base-pair may account for the decrease in peptide 
phosphorylation from the 24 base-pair DNA compared to the 30 base-pair duplex 
effector (compare Figures 8 and 10).  Finally, we conducted autophosphorylation 
experiments both in the presence and the absence of the peptide substrate to ensure 
that our autophosphorylation results were consistent with the peptide-based kinase 
assays.  Similar results were seen under both conditions (data not shown).  These 
results indicate that length dependence may play a role in influencing 
autophosphorylation. 
Once having determined that a single-strand overhang on the terminus of a 
duplex DNA effector does not increase DNA-PK activity as compared to a full 
duplex DNA effector, we designed a series of DNA effectors with homopolymeric 
overhang strands.  Our previous publication indicated that DNA sequence, 
particularly terminal sequence, differentially affects DNA-PK activation [51].  Thus, 
to determine if DNA-PK exhibits sequence bias on a single-strand overhang effector, 
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we assessed kinase activity (phosphorylation of a synthetic peptide) with 
homopolymeric overhang strand effectors.  One set of effectors had 3’ 6-base 
extensions of Ts or As (Figure 12), and this terminus was rendered the only 
accessible terminus by the presence of streptavidin on the opposite end.  The other set 
of effectors was identical except the extensions were on the 5’ strand of the accessible 
terminus (Figure 13).  Triplicate assays were performed at two different DNA 
concenterations (0.5 pmol and 1.0 pmol) and in triplicate, and results revealed that 
DNA-PK activity from the 3’ A overhang effector was slightly decreased compared 
to activity from the 3’ T overhang effector.  This effect was observed at both 
concentrations (Figure 12), and mimics previous work we have done looking at 
sequence bias and DNA-PK activation where we showed differential activation of 
DNA-PK resulting from pyrimidines versus purines [51].  Interestingly, we also 
observed a decrease in activation from the 5’A overhang DNA effectors compared to 
the 5’T overhang effectors (Figure 13).  Finally, comparison of 3’ and 5’ overhang 
effectors showed greater activation from the 5’ DNA effectors as compared to 3’ 
overhang (compare overall pmol transferred in Figure 12 and 13).  This result is 
independent of sequence, and is completely consistent with our previous results 
showing that 5’ extensions result in greater activity than 3’ (Figure 8). 
When designing the set of effectors with homopolymeric sequences, we 
designed them such that when individually included in a reaction, the extensions are 
non-compatible and thus each terminus presumably binds a single DNA-PK.  
However, when two effectors are combined together in a reaction, they are capable of 
annealing, and could potentially form a synaptic complex (Figure 3).   
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Figure 12.  Dimeric activation of DNA-PK from effectors containing 3’ 
compatible homopolymeric overhang ends. Effectors with a 6-base poly-T 3' 
overhang or a 6-base poly-A 3' overhang were pre-bound with heterotrimeric DNA-
PK and assayed for DNA-PK kinase activation. Assays were conducted with either 1 
or 0.5 pmol of each effector per reaction, as indicated, or 0.5 pmol of each effector 
was incubated together in a single reaction. 0.5 pmol of the poly-T effector is 
indicated by a white plus symbol, and half a pmol of the poly-A effector is indicated 
by the black plus symbol. Results are presented as the picomoles of 32P transferred to 
the synthetic p53 peptide in a 30-min reaction. Reactions were performed in triplicate 
and the mean and standard deviation are presented. 
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Figure 13.  Dimeric activation of DNA-PK from effectors containing 5’ 
compatible homopolymeric overhang ends.  Effectors with either a 6-base poly-T 
5' overhang or a 6-base poly-A 5' overhang were assayed for DNA-PK kinase 
activation as described in Figure 12. 0.5 pmol of the poly-T effector is indicated by a 
white plus symbol, and half a pmol of the poly-A effector is indicated by the black 
plus symbol. 
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These regions of complementarity mimic regions of microhomology such as those 
that occur in a cell.  This experiment was performed by pre-incubating each DNA 
effector with DNA-PK (5 minute incubation), then incubating these pre-formed 
complexes together for five minutes before initiating the kinase reaction with the 
addition of 32P-ATP.  It is important to note that each individual effector reaction was 
performed at two different concentrations, one being equal to the total DNA 
concentration in the combined reaction (1.0 pmol, Figure 12, bars 1 and 2) and one 
being equal to half the DNA concentration of the combined reactions (0.5pmol, 
Figure 12, bars 3 and 4).  The experiment was designed this way in order to increase 
the level of activation resulting from the relatively poor DNA effectors as well as to 
control for total DNA in the combined reaction (where 0.5 pmol of each DNA 
complementary DNA effector was added, Figure 12, bar 5).  In the reactions 
containing two 3’ overhang effectors with complementary overhangs, a significant 
increase in activation was observed (Figure 12, bar 5) compared to the individual 
reactions that only contained one DNA overhang effector (at 0.5pmol or 1.0 pmol).  If 
kinase activation was additive when combining the DNA effectors containing regions 
of complementarity, in this reaction we would have expected to see the sum of the 
activity resulting from the each DNA effector at 0.5 pmol concentration (Figure 12, 
bars 3 and 4), approximately 85 pmol of phosphate transferred.  Furthermore, if we 
consider an average of the individual reactions at equal concentrations of total DNA 
(1 pmol, Figure 12, bars 1 and 2), we would expect approximately 65 pmol of 
phosphate transferred.  Instead, DNA-PK activity resulting from combining two DNA 
effectors with regions of microhomology in the overhang strands resulted in 190 pmol 
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of phosphate transferred (Figure 12, bar 5).  This synergistic level of kinase activity is 
dependent on the presence of compatible DNA termini and suggests that annealing of 
DNA ends influences DNA-PK activation. 
The above results suggest that compatible DNA termini may play a role in 
DNA-PK activation.  However, the described experiments do not reveal how strand 
orientation and polarity play a role in activation.  In an effort to determine if strand 
orientation of a microhomologous sequence plays a role in synergistic levels of 
activation, we performed experiments in the same manner as Figure 12 with effectors 
containing identical sequences and structures as those seen in Figure 12, but with 5’ 
extensions.  5’ overhang effectors with compatible termini did produce a slight level 
of synergistic activation when incubated together in a reaction (Figure 13, bar 5) as 
compared to control reactions (Figure 13, bars 1-4), but this level of synergy was not 
nearly as great as that seen from incubating DNA effectors with 3’ overhang 
compatible termini together.  Additive results (0.5 pmol of each 5’ overhang effector, 
Figure 13 bars 2-3) predicted 137 pmol of phosphate transferred, while averaging 
each reaction (1 pmol of each effector, Figure 13 bars 1-2) predicts a value of 130 
pmol of phosphate transferred.  The level of activity actually observed from 
incubating two effectors with 5’ overhang regions of complementarity together is 
slightly synergistic, with 171 pmol of phosphate transferred (Figure 13, bar 5), but 
this increase in activity over the predicted additive and average values is not nearly as 
great as the synergistic increase seen with the 3’ overhang effectors.  These results 
indicate that the 3’ end (over the 5’ end) of a DSB is important for the DNA-PK 
dependent aligning and microhomology directed ligation at the site of a DSB. 
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 The results described above indicate that complementary sequences in a 3’ 
overhang region of a DNA effector have an effect on DNA-PK activation.  However, 
as the described regions of microhomology are composed of homopolymeric 
sequences, we were concerned that these areas have the potential for annealing in 
different positions, with the potential for 2-, 3-, 4-, 5- or 6 bp annealing.  This would 
create different protein-DNA structural complexes, with the possibility for varying 
lengths of nucleotide gaps to exist between the two complexes.  To correct and 
control for this possibility, effectors were designed with a complementary mixed 
sequence on the 3’ overhang.  These effectors can only anneal in a single position, 
and so would only contain a nick at each junction following annealing.  The kinase 
assay was conducted as described above, and results show that like effectors with 
homopolymeric regions of complementarity, effectors with 3’ overhangs containing a 
specific annealing sequence also induce high levels of synergistic activity, 256 pmol 
of phosphate transferred (Figure 14).  This level is significantly higher than the 
projected additive and average values, 136 and 108 pmol of phosphate transferred.  
These results support the conclusion that the 3’ end is necessary for microhomology-
associated annealing and solidifies the hypothesis that microhomology is important 
for DNA-PK activation, as the complementary sequence in these effectors is 
significantly more specific than the DNA effectors used in Figure 12.  This indicates 
that the synergistic level of activity, now referred to as dimeric activation, results 
from two effectors having the ability to successfully anneal, and that this requires 
greater than one complementary base.   
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Figure 14.  Activation of DNA-PK with DNA effectors containing compatible 
mixed sequence overhang ends. Effectors with 6-bp 3' overhang complementary 
sequences were pre-bound with DNA-PK and assayed for DNA-PK activation as 
described in Figure 12. Assays were conducted with 1 pmol or 0.5 pmol of a single 
DNA effector, or 0.5 pmol of each effector was included together in a reaction, as 
indicated. The white plus symbol indicates half a pmol of one DNA effector, and the 
black plus symbol indicates the second effector with a complementary overhang. 
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 We hypothesized that the DNA-PK dimeric activation resulting from DNA 
effectors with compatible 3’ overhang termini was due to an increase in formation of 
a synaptic complex between the two DNA effectors and the two DNA molecules.  To 
test this, we designed a pull-down assay utilizing radiolabeled DNA.  This assay was 
conducted under similar conditions as the kinase assays, as described in Materials and 
Methods.  Briefly, one unlabeled DNA effector was bound to streptavidin-conjugated 
magnetic beads, and a 32P labeled effector with a complementary overhang sequence 
was bound to streptavidin molecules.  DNA-PK was then pre-bound to each DNA 
effector (streptavidin-bead bound and streptavidin-molecule bound DNA effectors) 
individually, incubated together, washed extensively, and radioactive counts were 
read in a scintillation counter (Figure 15).  Increase in radioactive counts corresponds 
to an increase in synaptic complex formation, and results are presented as a percent of 
total radiolabeled DNA-PK-DNA complex bound to unlabeled DNA-DNA-PK 
complex.  Results from this assay revealed that a synaptic complex is formed in the 
presence of DNA overhang effectors and DNA-PK, as shown by the increase in 
percent bound in the reactions containing samples with pre-bound DNA-DNA-PK as 
compared to the reactions that were absent of DNA-PK (Figure 16, compare bars 1 
and 2 and 3 and 4).  Interestingly, DNA overhang effectors with DNA-PK bound to 
them formed a synaptic complex regardless of the presence of a region of 
microhomology within the overhang (Figure 16, bars 1 and 3).  This result differs 
from kinase activity observed from overhang effectors containing regions of 
microhomology, as activity in kinase assays was increased with DNA overhang 
effectors with regions of microhomology.  These results deomonstrate that homology  
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Figure 15.  Schematic of DNA-PK synaptic complex formation assay with 
overhang effectors.  A 32 P labeled DNA effector was pre-bound with streptavidin 
(indicated in purple) and a unlabeled effector with complementary overhang sequence 
was bound to streptavidin conjugated magnetic beads.  DNA-PK (indicated in yellow) 
was then pre-bound to each of these DNA effectors individually.  These two reactions 
were incubated together, washed, and radioactive counts were read in a scintillation 
counter. 
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Figure 16.  DNA-PK synaptic complex formation with DNA effectors containing 
compatible overhang ends. Five hundred femtomoles of each unlabeled DNA 
effector was bound to streptavidin magnetic beads. 32P-labeled DNA (indicated by 
asterisk) and the SA bound unlabeled DNA was incubated with DNA-PK or buffer as 
indicated, and labeled DNA was incubated in a separate tube with DNA-PK or buffer 
for 5 min. The labeled DNA effector prebound with DNA-PK or buffer was added to 
the tubes containing SA-unlabeled DNA and DNA-PK or buffer, incubated for 5 min, 
washed, and counts were read in a scintillation counter. Results are presented as 
percent of total DNA-DNA-PK complex bound to SA – DNA – DNA – PK complex. 
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driven dimeric activation seen in our kinase assays is a catalytic effect, and does not 
result from increased binding and formation of a synaptic complex.  
 Many studies over the years help us understand the mechanism of activation 
of this unique DNA-dependent protein kinase.  Convincing biochemical and 
structural data have shown that DNA makes contact with DNA-PK, and recent higher 
resolution structural studies present a model where DNA threads through a channel in 
the protein kinase.  Furthermore, it has been postulated that DNA structure, chemistry 
and sequence play an important role in activation of the kinase.  However, precisely 
how DNA serves to activate DNA-PK is still an open question.  The results we have 
gathered show that in a Ku-dependent DNA-PK kinase assay, Y-shaped effectors 
with single-strand ends result in activity that is similar to that seen from full duplex 
DNA effectors.  However, the presence of single-strand overhangs results in 
significantly less activity.  This finding differs from kinase assay results using Ku-
independent DNA-PKcs, where a significant increase in activity was observed with 
DNA effectors containing single-strand ends [53].  Although this study revealed 
interesting mechanistic insights, this design is perhaps not the most physiologically 
accurate way to study mechanisms of DNA-PK.  It has been shown in vivo that Ku 
recruits DNA-PKcs to the site of a DSB, and furthermore that DNA-PK kinase 
activity is significantly increased in the presence of Ku [61].  This illustrates the 
importance of including the holoenzyme (Ku and DNA-PKcs) when studying 
mechanism of activation.  Furthermore, the difference in activation from DNA-PKcs 
versus DNA-PK (the holoenzyme) resulting from a single-strand end may be 
3.3.  Discussion 
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explained in part by an energetic argument.  The presence of Ku at the termini 
eliminates the need for having pre-separated DNA strands, and this suggests that Ku 
promotes strand opening in conjunction with DNA-PKcs.  This is supported by recent 
work arguing that Ku is able to “peel away” DNA termini from a histone surface at 
the site of a DSB, suggesting that the Ku structure does more than just thread onto 
DNA [37].  Recent work has also suggested that Ku may also play a role in end-
processing during NHEJ, again supporting the theory that Ku could have some sort of 
influence in opening up DNA at the site of the break [110].  In any event, Ku 
facilitation of unwinding in conjunction with DNA-PKcs to generate the required 
single-strand ends could explain the differential activation as a function of single 
strands between assays with DNA-PKcs alone and with the heterotrimer. 
 The inhibition of DNA-PK activity resulting from a 3’ overhang compared to 
a 5’ overhang DNA effector, combined with the synergistic activity exhibited from 
complementary overhangs suggests that each single-strand terminus plays a unique 
role in DNA-PK activation.  These results suggest that the 5’ end of DNA is more 
important contact with the kinase, thus resulting in a greater degree of activation than 
the 3’ end (Figure 8).  Interestingly, each strand on their does not result in maximal 
activation of DNA-PK (as compared to double strand DNA of the same length).  This 
indicates while each strand plays an important and unique role in activation of the 
kinase, both strands are still necessary maximal DNA-PK activation.   
 Based on the data presented above and structural and enzymatic analysis that 
has emerged over the last five years in the NHEJ field, we have developed a more 
complex model for activation of DNA-PK (Figure 17).  Following Ku binding and 
74 
 
recruitment of DNA-PKcs to the site of the break, the kinase binds to the DNA 
terminus.  The DNA strand is postulated to protrude through the kinase, with the 
terminus appearing on the opposite opening of the kinase.  Following insertion 
through the kinase, evidence points to fraying or unwinding of the DNA end [54].  
Our data show that a DNA fragment with a 5’ overhang induces greater DNA-PK 
activation than a DNA fragment with a 3’ overhang.  Yet, when two complementary 
3’ overhang DNA effectors are incubated together, a synergistic level of DNA-PK 
activation is observed.  When two pieces of DNA with 5’ complementary overhangs 
are incubated together, the synergistic level of activation is significantly lower.  
Combined, this data suggests that the 5’ strand is important for activation, while the 
3’ strand may be important in scanning for regions of microhomology.   
Previous studies suggest the possibility that following fraying of the DNA 
ends after DNA-PK binding, the strands may insert themselves into active sites on the 
perimeter of the kinase [55].  Our data suggests that each DNA termini is bound by 
DNA-PK in a dimeric, or synaptic, complex independent of homology. The DNA is 
scanned for regions of microhomology, which potentially pulls the DNA further 
through the kinase.  Once homologous regions are identified increased kinase activity 
results.   The model predicts that this activation is accompanied by insertion of the 5’ 
end into the active pocket on the periphery of the kinase (Figure 17 D, E).  The 
formation of this synaptic complex and subsequent dimeric activation is expressed as 
a synergistic level of activity when the two complementary effectors are incubated 
together in an assay for DNA-PK activation.  This process could be viewed as 
“useful” to NHEJ, as having the ability to scan for and identify regions of  
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Figure 17.  Model for activation of DNA-PK. DNA, depicted in black and orange, 
threads through DNA-PK, depicted in yellow. (A) When DNA of adequate length 
threads through the kinase, the ends separate and the 5' end can insert itself into an 
active site on the periphery of the kinase. (B) A 5' overhang containing effector can 
activate in the absence of dimerization while a 3' overhang (C) displays less 
activation. When the 3' overhang possesses a complementary sequence to the second 
DNA molecule with a 3' overhang, the two DNA ends can anneal, thus orienting the 
two DNA-PK molecules into a synaptic complex. The annealing may allow for more 
DNA to thread through the kinase, potentially making more of the 5' strand accessible 
for kinase activation. This activation could then occur in either a cis (D) or trans (E) 
fashion. 
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microhomology would allow for repair of a DSB without massive removal of 
nucleotides on flanking sequences, thus preserving genetic material.  Furthermore, it 
is possible that annealing of 3’ complementary termini releases the 5’ strand for use 
in activating the kinase.  Therefore, it is reasonable that 3’ regions of microhomology 
increase overall kinase activity, as this would most likely increase overall NHEJ. 
It is believed that when DNA-PKcs is bound to the ends of two DNA 
molecules at the site of a DSB, the protein kinase is responsible for bringing the two 
DNA ends into proximity of each other, in what is now called a synaptic complex.  
The formation of this synaptic complex is thought to be through the dimerization of 
DNA-PK.  In fact, recent structural data indicates that the C-terminal region of Ku80 
is both long enough and flexible enough to make contact with a DNA-PK molecule 
on the opposing strand.  This could potentially be one of the factors responsible for 
formation of a synaptic complex being formed between two DNA-PK holoenzyme 
complexes bound to the two DNA termini at a DSB.  Furthermore, it is thought that 
dimerization of DNA-PKcs and subsequent formation of the synaptic complex results 
in maximal activation of the kinase [14].  Our results are consistent with a model 
where dimerization of DNA-PK is independent of microhomology (Figure 13), but 
kinase activity is greatly influenced by end annealing.  In short, synergistic activation 
of DNA-PK as driven by microhomology is a kinetic event. 
There are two models one can envision for the role of DNA in activation of 
the kinase once these molecules are brought within proximity.  One model involves 
the frayed 5’ DNA end being inserted into the active site of the same DNA-PKcs 
molecule to which the DNA is bound [51, 54], in a cis orientated model (Figure 17D).  
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The second model positions the 5’ strand interacting with the DNA-PKcs molecule 
that is bound to the opposite DNA strand, in a trans orientated model (Figure 17E) 
[53].  This model is supported by data suggesting that DNA-PKcs is 
autophosphorylated in trans [82].  Recent work in Mycobacterium tuberculosis 
suggests that the 3’ ends of DNA at each terminus of a double strand break are 
important in maintaining a synaptic complex consisting of the NHEJ machinery. The 
authors propose that the 3’ ends protruding from each LigD (analogous to DNA-PK 
machinery in eukaryotes) molecule can pair together, thus bringing each LigD-bound 
DNA termini into proximity of each other in a synaptic complex [111].  Further 
research in eukaryotes needs to be done to determine more precisely the role of the 3’ 
and 5’ ends in DNA-PK activation and synaptic complex formation. 
It is important to point out that NHEJ-dependent joining of blunt-end 
substrates can occur in vitro and in cell culture models.  These termini could be joined 
independent of microhomology, and would serve in the true sense of “non-
homologous” end-joining, as the two blunt ends could simply be ligated together with 
no microhomology-dependent activity.  This kinase activation mechanism may not 
necessarily include fraying of the termini or nuclease processing to reveal regions of 
microhomology.  Consistent with this theory is the fact that blunt-end DNA effectors 
still provide the highest level of kinase activity in vitro, over single-strand DNA ends.  
However, as we have shown in the physiologically relevant context of a DNA-PK 
dependent synaptic complex formed at the site of DSB, DNA with regions of 
microhomology increases kinase activation.  This kinetic data of ours is supported by 
work revealing that 3’ or 5’ overhang complementary DNA ends were joined much 
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more efficiently than blunt ends in cell-free NHEJ assays [9, 112].  This data suggests 
that the preferred in vivo NHEJ substrate could potentially undergo strand separation 
or contain single-strand overhangs, as well as possess regions of microhomology.  
Clearly, more experimental evidence needs to be obtained to understand precisely 
how DNA termini affect kinase activation, and this work needs to be expanded to 
look at how microhomology and DNA-PK activation affect NHEJ in vivo. 
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4.  Purification of exonuclease-free Artemis and implications for DNA-PK 
dependent processing of DNA termini in NHEJ-catalyzed DSB repair 
 Ionizing radiation induced DNA DSB repaired by NHEJ can contain other 
DNA structural damage including thymine glycols, ring fragmentation, 3’ 
phosphoglycolates, 5’ hydroxyl groups and abasic sites.  These DNA discontinuities 
that arise around DNA termini at the site of a DSB usually need to be processed 
before ligation of the DSB by the XRCC4/Ligase IV/XLF complex can occur [1].  
Many enzymes have been implicated DNA termini processing during NHEJ, 
including polymerases, kinases, and nucleases.  Artemis, a 76 kDa nuclease, plays a 
role in cleavage of DNA termini during NHEJ [74]. 
4.1.  Introduction 
 Artemis, a member of the metallo-β-latamase family and the β-CASP 
subfamily of enzymes, has been shown to have DNA-PK dependent endonuclease 
activity on DNA hairpin structures, and DNA-PK dependent endonuclease processing 
of 3’ and 5’ single-strand overhangs, with preferential cleavage at the dsDNA/ssDNA 
junction [74].  While specific mechanistic models of Artemis endonuclease activation 
vary, it is clear that Artemis endonuclease activity is DNA-PK and ATP dependent.   
Artemis has also been suggested to possess an intrinsic 5’-3’ DNA-PK independent 
exonuclease activity based on in vitro analysis of partially purified preparations of 
Artemis.  However, recent studies raise questions about wether Artmies has intrinsic 
exonuclease activity.  In vitro studies have identified the catalytic domain and then 
most recently, a specific amino acid required for endonuclease activity of Artemis.  
Interestingly, mutational analysis of several conserved residues within the catalytic 
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domain successfully disrupts the endonuclease activity, but each of these mutants still 
maintains robust exonuclease activity [103, 113].  This could be a result of Artemis 
having two independent catalytic sites within the polypeptide, one for each activity 
(endonuclease and exonuclease).  However, this would make Artemis a unique 
enzyme within its family, as metallo-β-lactamase fold enzymes have been classified 
as only having one active that has been shown to be the functional catalytic site for all 
activities [114].  Furthermore, the exonuclease activity has not yet been shown to 
have a role in vivo, whereas the endonuclease activity has been demonstrated both in 
vitro and in vivo [115].  While a variety of purification protocols have been used to 
obtain a purified form of Artemis, all preparations to date still include both 
exonuclease and endonuclease activity.   
There is currently considerable conflict in the field regarding classification of 
the activities of Artemis.  Clearly, understanding the true nature of a protein’s activity 
will lead to a greater understanding of the role of this enzyme in NHEJ.  To resolve 
these apparent discrepencies, we pursued the fractionation of Artemis in a baculovirus 
expression system to determine of the exonuclease and endonuclease activities were 
biochemically separable.  We developed a three step purification protocol which 
results in the separation of the exonuclease activity from the intrinsic endonuclease 
activity of Artemis.  Biochemical analyses revealed that the exonuclease activity 
associated with Artemis is not intrinsic to the Artemis polypeptide.   
 N-terminal [His]6 tagged human Artemis was cloned and overexpressed in 
insect cells as described in Materials and Methods.  Briefly, the full length Artemis 
4.2.  Results 
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coding region from GenBank was cloned from a cDNA library using standard PCR 
techniques.  The cDNA was then sub-cloned into the pRSET-C vector (Invitrogen) to 
generate a N-terminal [His]6 tagged Artemis fusion construct.  To generate a 
recombinant baculovirus for expression of [His]6-Artemis in insect cells (Clontech), 
this construct was subcloned into the pBacPA8 vector to generate BacPAK8-Art-His 
(Figure 18).  This construct was transfected into SF9 insect cells using Bsu36I-
digested BacPAK6 viral DNA (Clontech).  The recombinant virus generated from the 
transfected cells was collected, plaque purified, and expanded according to 
manufacturer’s directions.  This expanded recombinant virus was used to infect SF9 
cells to generate expression of [His]6-Artemis protein.  Following overexpression, 
Artemis was fractionated by three steps including anionic exchange, nickel affinity 
and hydroxyapatite column chromatography (Figure 19A). 
 A cell-free extract was prepared from insect cells expressing human 
recombinant [His]6-Artemis fusion protein.  To detect Artemis overexpression in the 
cell-free extract, we analyzed the extracted protein by SDS-PAGE, western blot and 
phosphorylation by DNA-PK.  Coomassie Blue staining of an SDS denaturing gel 
revealed expression of the [His]6-Artemis protein (Figure 19B).  This expression was 
further confirmed by western blot analysis, and this revealed a dominant band at the 
expected molecular mass (~110 kDa) for the recombinant His-tagged fusion protein.  
This analysis was performed with using both a monoclonal antibody against the N-
terminal [His]6 fusion tag (Figure 19C) and a polyclonal antibody against the full 
length Artemis polypeptide (data not shown).  Artemis has been shown to have eleven 
serine/threonine residues that are phosphorylated by DNA-PK in vitro [73].   
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Figure 18.  Map of BacPAK-Art-His.  The Artemis gene with a N-terminal [His]6 
tag was subcloned into the BakPAK-8 vector for transfection into SF9 insect cells.  
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Figure 19.  Purification scheme for [His]6-Artemis.  (A)  A whole cell extract 
prepared from SF9 insect cells expressing [His[6 –Artemis was fractionated over a 
phosphocellulose column.  The flow-through was applied to a 2 mL Nickel-Agarose 
column, and [His]6-Artemis was  eluted with 200 mM imidazole.  Pooled fractions 
were further fractionated over a 5mL hydroxyappatite column.  The FT containing 
[His]6-Artemis and elution containing exonuclease activity were collected from the 
HAP column.  (B) Analysis of whole cell extract from SF9 insect cells containing 
over-expressed Artemis-[His]6.  Coomassie-stained SDS-PAGE gel of the whole cell 
extract (2.5 µg) made from insect cells infected with recombinant [His]6-Artemis 
baculovirus.  (C) Western blot analysis of whole cell extract (2.5 µg) using the anti-
Xpress antibody, as described in Materials and Methods.  (D) Phosphorylation of 
Artemis by DNA-PK was measured by incubating whole cell extract containing 
[His]6-Artemis (5 µg) with 60 nM DNA-PK in presence of 100 nM 30-mer full 
duplex DNA, 125 µM ATP and 1.0 µCi [γ-32P]-ATP as described in Materials and 
Methods.  Reactions were terminated by addition of SDS, separated by 8 % SDS-
PAGE, and the gel was dried and exposed to a PhosphorImager.  Arrow depicts 
phosphorylated Artemis or DNA-PKcs product on each gel. 
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Therefore, to confirm that the baculovirus expressed [His]6-Artemis that we made can 
be phosphorylated by DNA-PK, we conducted an in vitro DNA-PK phosphorylation 
reaction as described in Materials and Methods.  Briefly, the cell-free extract was 
incubated with purified DNA-PK, double-strand 30-mer DNA to stimulate DNA-PK 
kinase activity, and [γ-32P] ATP.  Reaction products were separated by SDS-PAGE 
and incorporation of the radioactive phosphate into the Artemis protein was detected 
by PhosphorImager analysis.  As seen with Commassie staining and western blot 
analysis, the kinase reaction resulted in a prominent band at the anticipated size for 
[His]6-Artemis (Figure 19D).  This band is indicative of DNA-PK-dependent 
phosphorylation of [His]6-Artemis in the cell-free extract. 
 After preparation of the whole cell extract from insect cells infected with 
recombinant [His]6-Artemis baculovirus, the potassium chloride concentration in the 
extract was increased to 0.5 M and subsequently mixed with phosphocellulose 
chromatography media, a cation exchange resin used to separate proteins based on 
charge via ion exchange.  Raising the salt concentration up so high in the extract 
allowed for the majority of the protein in the extract (including [His]6-Artemis) to 
flow through the matrix.  This flow-through was collected and immediately loaded 
onto a 2 mL nickel-NTA agarose column, nickel-charged affinity resin that can be 
used to purify recombinant proteins containing a polyhistidine (6xHis) sequence like 
[His]6-Artemis has.  Following loading of extract, the column was washed 
extensively with high ionic strength buffer followed by low ionic strength buffer, 
both of which contained 5 mM imidazole.  The washes were performed to eliminate 
non-specific, low affinity binding of proteins from the extract to the Ni-NTA column.  
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As his-tagged proteins bound to a Ni-NTA protein can be eluted by competition with 
imidazole, the bound protein was eluted with buffer containing 200 mM imidazole 
and collected in 1 mL fractions.  Analyses of eluted proteins showed that the majority 
of [His]6-Artemis bound to the Ni-NTA agarose matrix and was eluted with 200 mM 
imidazole.  The load, flow-through and eluate from the nickel column were analyzed 
by SDS-PAGE and stained with Coomassie Blue (Figure 20A).  Further verification 
was performed by western blot analysis (Figure 20B ) and phosphorylation by DNA-
PK (Figure 20C).  Each assay revealed that the majority of the Artemis applied to the 
column was retained in the imidazole elution (Figure 20A-C, compare lanes 1 and 3).  
Importantly, as this procedure was repeated several times, we discovered that 
retention of Artemis on the Ni-matrix was extremely sensitive to chromatographic 
conditions to the presence of reducing agents, with greater than anticipated amount of 
Artemis remaining in the flow-through under less than optimal conditions (data not 
shown).  Thus, reducing agents should be avoided in purification buffers in an effort 
to maximize protein yield.  While the results from fractionation over a Ni-NTA 
column indicate a degree of purity of [His]6-Artemis, the Coomassie Blue stained gel 
and phosphorylation assay reveal significant impurities in the eluate.  While not 
necessarily a surprising result, these results indicate the need for further fractionation 
to achieve a higher degree of purity. 
 In our attempts to further purify [His]6-Artemis, the majority of the matrices at 
our disposal were assessed, including various anion (DEAE and Q-sepharose 
matrices) and cation exchanage chromatography (S-sepharose matrix), adsorption 
chromatography (Heparin-sepharose matrix) as well as hydrophobic interaction  
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Figure 20.  Analysis of fractionation on a Nickel-Agarose column.  (A) 
Coomassie-Blue stained 8 % SDS-PAGE of pools from Nickel-Agarose column.  The 
bracket indicates anticipated position of  [His]6-Artemis migration. (B) Western blot 
analysis using the anti-Xpress antibody against a portion of the 6xHis tag 
(Invitrogen).  (C) Phosphorylation of Nickel-Agarose pools by DNA-PK.  For A, B 
and C, Lane 1, Nickel-Agarose load, Lane 2, Nickel-Agarose flow-through, Lane 3, 
Nickel-Agarose pool.  All assays were conducted as described in legend for Fig. 19 
and arrows indicate migration the position of Artemis. 
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chromatography (Phenyl-sepharose matrix).  The results from these matrices were 
universally poor (data not shown).  However, fractionation by adsorption 
chromatography on a hydroxyapatite (HAP) matrix resulted in substantial purification 
of [His]6-Artemis.  HAP matrix consists of positively charged calcium ions and 
negatively charged phosphate groups.  The protein-matrix interaction is complicated, 
but briefly, involves attraction of the positively charged amino groups and negatively 
charged carboxyl groups in protein to the negatively charged phosphate ions and 
positively charged calcium ions in the matrix.  Typically, bound protein is eluted off 
HAP matrix by increasing phosphate concentration in a buffer with a pH of 6.5-7.0.  
It is important to point out that the success rate of separation on this column was 
achieved at a relatively high pH of 7.8.  The majority of total protein applied (greater 
than 90 %) was retained on the HAP column, but interestingly the majority of [His]6-
Artemis was not retained on the HAP column and instead was found to be in the 
flow-through fractions.  Western blot analysis of the flow-through fractions (Figure 
21A) and elution fractions (21B) confirmed that the vast majority of [His]6-Artemis 
was recovered in the flow-through fractions.  Furthermore, Coomassie Blue staining 
of SDS-PAGE with the HAP load and flow-through fractions confirmed that the HAP 
FT pool had overall decreased non-specific protein while retaining Artemis (Figure 
21C).  Unfortunately, [His]6-Artemis overexpression in baculovirus does not result in 
rampant overexpression of the protein, so definitive identification of Artemis by 
Coomassie Blue staining of SDS-PAGE is difficult.  However, the Artemis 
containing flow-through fractions were pooled and Artemis levels in each were 
determined by the more quantitative in vitro phosphorylation analysis.   
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Figure 21.  Analysis of hydroxyapatite (HAP) column fractionation of Artemis.  
(A) Western blot analysis of load and flow through fractions and (B) fractions 
obtained from the gradient elution.  Aliquots of each fraction were separated by SDS-
PAGE, transferred, probed with anti-Xpress antibody and detected as described in 
“Methods”.  (C) Coomassie-Blue stained SDS-PAGE analysis of the load and flow-
through fractions.  Samples were processed as described in “Methods”.  The bracket 
indicates anticipated position of [His]6-Artemis migration. (D) Phosphorylation of 
[His]6-Artemis by DNA-PK.  Reactions were performed as described in the legend 
for Figure 19.  Lane 1, HAP flow-through pool (140 ng), Lane 2, DNA-PK control 
without Artemis.  Lane 3, HAP elution pool (190 ng).  Arrows indicate phosporylated 
[His]6-Artemis and DNA-PKcs.    
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This confirmed that the overwhelming majority of the Artemis protein was present in 
the flow-through pool and could be successfully phosphorylated by DNA-PK (Figure 
21D, lane 1), as compared to control reactions without the HAP FT (lane 2).  
Phosphorylation of the protein in the HAP elution pool by DNA-PK revealed little to 
no phosphorylation of Artemis, suggesting that no Artemis protein was eluted from 
this column (lane 3). 
 Having confirmed the presence of the Artemis polypeptide following 
fractionation over a HAP column, we wanted to determine how HAP fractionation 
affected the retention of 5’-3’exonuclease activity, postulated to be an intrinsic 
enzymatic activity of Artemis.  To determine exonuclease activity, we assayed the 
column fractions from the HAP column for 5’-3’ exonuclease activity using a 34-base 
single-strand oligonucleotide with a 5’ [32P]-label.  The release of a 5’ radiolabeled 
nucleoside monophosphate is a direct measure of any 5’-3’ exonuclease activity 
(Figure22A).  Nuclease products are visualized by separating the reactions on a 
denaturing gel as described in Materials and Methods.  Surprisingly, the majority of 
the exonuclease activity was resolved in six fractions that bound to the column and 
were then subsequently eluted during the phosphate gradient.  Minimal exonuclease 
activity was found in the flow through fractions (Figure 23A).  Quantification of the 
gel-based exonuclease assay further demonstrate that a small portion of the overall 
exonuclease activity loaded onto the HAP column was identified in the flow-through, 
while the majority was located in the eluate (Figure 23B).  It is important to note that 
measurement of the bound exonuclease activity is potentially an underestimation, as 
all of the substrate was completely degraded in the peak elutions (fractions 48-50, 
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Figure 23A and 23B).  The exonuclease containing fractions were pooled and 
quantitative nuclease and Artemis expression analysis was performed.  The percent of 
total antibody reactivity or exonuclease activity resolved in the two pools of protein 
(flow-through and elution) was determined and the results demonstrate that greater 
than 90 % of Artemis protein loaded onto the HAP column was recovered in the HAP 
flow-through material, while less than 10 % was recovered in the gradient elution 
pool.  In accordance with Figure 23A and 23B, only 10 % of the overall exonuclease 
activity loaded onto the HAP column was identified in the flow-through, while 90 % 
of it was located in the eluate (Figure 23C).  As seen in Figure 21, the majority of the 
Artemis polypeptide was found in the flow-through fractions and minimal Artemis 
was in the elutions, while enzymatic results show that the majority of exonuclease 
activity is in the elutions and not the flow-through.  These results suggest that [His6]-
Artemis does not bind to a HAP column under specific fractionation conditions while 
the majority of exonuclease activity remains bound under these same conditions and 
can be eluted with high phosphate. 
 Discussions with colleagues within the field led to questions concerning the 
origination of the exonuclease activity found in our Artemis prep.  We designed a 
purification experiment to determine whether the exonuclease activity is a 
contaminating nuclease that has a high affinity for a nickel-agarose column.  To 
accomplish this, we overexpressed another His-tagged DNA repair protein, XPA, 
using recombinant baculovirus.  This DNA-binding protein, frequently used in our 
lab, has no intrinsic nuclease activities and minimal protein interaction domains.  
Following expression of recombinant [His]6-XPA in insect cells using baculovirus  
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Figure 22.  Exonuclease activity and DNA-PK dependent endonuclease activity.  
(A) Exonuclease activity.  Exonucleases cleave phosphodiester bonds at the end of 
polynucleotide chains.  (B) Endonucleases cleave phosphodiester bonds internally, 
producing polynucleotide or oligonucleotides.  The nuclease Artemis cleaves 
phosphodiester bonds internally to produce oligonucleotide fragments in the presence 
of DNA-PK and ATP. 
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Figure 23.  Quantitative assessment of exonuclease activity from HAP 
fractionation of [His]6-Artemis.  (A) A 2 µL aliquot of each 1mL HAP fraction 
from a [His]6-Artemis purification was assayed for exonuclease activity using a 
5’[32P] labeled single-strand DNA 30 bases in length.  Reaction products were 
separated and visualized as described in Materials and Methods.  (B) Quantification 
of exonuclease activity from (A).  (C) Quantified antibody reactivity and exonuclease 
activity from the HAP flow-through and HAP elution pools.  Total intensity of 
antibody reactivity was obtained from MultiGauge analysis (Fuji) of representative 
western blots and total exonuclease activity was quantified using ImageQuant 
(Amersham) analysis of product released.   
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expression system, a whole cell extract was prepared under the  same conditions and 
procedures as for [His]6-Artemis and the identical purification protocol that was used 
for overexpressed  [His]6-Artemis was applied to [His]6-XPA fractionation.  
Following fractionation over the nickel-agarose column and HAP column, fractions 
were assayed for exonuclease activity on a radiolableled DNA substrate.  Robust 
exonuclease activity was seen in the whole cell extract as well as in nickel-agaorse 
elution fractions.  Fractions from the nickel-agarose elution containing exonuclease 
activity and subsequently XPA protein were pooled and further fractionated over a 
HAP column as described for [His]6-Artemis.  As seen with the [His]6-Artemis preps, 
exonuclease assays from the HAP column loaded with XPA again revealed a minimal 
amount of exonuclease activity flowing through the column (Figure 24A and 24B).  
In addition, the peak of exonuclease activity eluted from the HAP column with the 
phosphate gradient coincides exactly with the peak of exonuclease activity eluted 
from the HAP column in the [His]6-Artemis prep.  Importantly, the low level of 
exonuclease activity seen flowing through the HAP column coincides with the low 
level of exonuclease activity seen flowing through the HAP column from the [His]6-
Artemis prep (compare Figures 23 and 24).  In order to further demonstrate that 
Artemis was not in the pool of protein with exonuclease activity, protein pools from 
the nickel-agarose elution, HAP flow-through and HAP elution were examined for 
DNA-PK dependent endonuclease activity.  All pools were completely devoid of 
DNA-PK dependent endonuclease activity (Figure 25). 
 Following our discovery of exonuclease separation via fractionation over a 
HAP column, we performed scrupulous quantitative analysis on the nickel-agarose  
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Figure 24.  Quantitative assessment of exonuclease activity from HAP fraction of 
a [His]6-XPA.  (A) A 2 µL aliquot of each 1mL HAP fraction from a [His]6-XPA 
purification was assayed as described in Figure 23. (B) Quantification of exonuclease 
activity from (A). 
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Figure 25.  Analysis of endonuclease activity on a 3’ radiolabeled DNA substrate 
with a 5’ single-strand overhang from [His]6-XPA preparation.  Reaction 
conditions were conducted as described in “Methods and Materials”.  The DNA 
substrate is depicted above the gel and the position of the [32P] label is denoted by the 
asterisk and the position of Artemis endonuclease activity is denoted by the carat.  
DNA strand lengths of each DNA substrate are also noted in the figure. A positive 
control demonstrating ATP dependent endonuclease activity in the HAP FT fraction 
from a [His]6 Artemis preparation is presented in lanes 1 and 2, while no 
endonuclease activity is observed in any fractions from the XPA preparation 3-8. 
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elution and HAP FT pools of protein to ensure that separation of enzymatic activities 
occurred.  A portion of each pool of protein, nickel-agarose elution and HAP FT, was 
dialyzed into identical buffer made up of 50 mM Tris pH 7.5, 200 mM KCl, 20 % 
glycerol and 1 mM DTT and succumbed to a battery of assays.  Dialysis into identical 
buffer was performed in an effort to minimize any difference in reaction conditions 
from the different buffers each pool of protein had originally been in that could affect 
enzymatic activities (inhibitory or stimulatory) of the pools of protein.  Comparison 
of the Ni pool and HAP FT by western blot analysis revealed the presence of a 
significant level of Artemis in each pool, as expected (Figure 26A) and this was 
confirmed by analysis of DNA-PK phosphorylation of each pool (Figure 26B and 
26C).  These results definitively prove that the Artemis polypeptide is located in both 
pools of protein from the nickel and HAP columns. 
As previously explained, the flow-through fractions from the HAP column 
retained minimal exonuclease activity on single-strand DNA, an activity in the 
literature previously attributed to the Artemis polypeptide (lieber cell 2002).  As seen 
in Figure 26, each pool of protein contained [His]6-Artemis and we wanted to directly 
compare the exonuclease activity in each pool of protein, Ni and HAP FT.  Increasing 
amounts of the nickel pool of protein and the HAP FT pool of protein were incubated 
with a 5’ radiolabeled oligonucleotide and release of the 5’ deoxynucleoside 
monophosphate (dNMP) was monitored.  Increasing concentrations of Ni pool 
containing Artemis resulted in increased 5’-3’ exonuclease activity.  In contrast, the 
Artemis containing HAP flow-through pool revealed an NMP product that was barely 
above the detection limit of our assay.  These results demonstrate that the HAP FT  
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Figure 26.  Identification of [His]6-Artemis polypeptide in Nickel-Agarose and 
HAP flow-through pools of protein.  (A) Western blot analysis.  Nickel-Agarose 
pool (200 ng, 1 µg and 2 µg) and HAP flow-through (10 ng, 20 ng and 50 ng) were 
analyzed by Western blot using an anti-Artemis antibody.  DNA-PK phosphorylation 
of Nickel (B) and HAP FT (C) pool of protein.  In vitro phosphorylation reactions 
were conducted as described in Materials and Methods and contained DNA-PK, 
[His]6-Artemis and DNA as indicated. Reaction products were separated via SDS 
PAGE and products visualized by phosphorImager analysis.   
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pool of protein does not contain 5’-3’ exonuclease activity (Figure 27A).  It is 
necessary to point out that there are preparation specific variations of exonuclease 
activity, and differences observed in the analysis of column fraction versus pools.  
Despite these differences, it is evident from results that the majority of the HAP 
polypeptide was flowing through the HAP column and this pool of protein was 
devoid of the majority of exonuclease activity. 
The more relevant activity of Artemis, found both in vitro and in vivo, is the 
DNA-PK dependent hairpin-opening activity and the 5’ and 3’ overhang 
endonuclease activity.  In an effort to ensure that the HAP FT pool of [His]6-Artemis 
devoid of exonuclease activity still retained its endonuclease activity, the Ni and HAP 
FT pools of protein were assayed for hairpin-opening activity.  To conduct these 
assays, a 5’ radiolabeled hairpin substrate containing a 6 base 5’ overhang was 
incubated with Ni or HAP FT pools of protein, buffer, heterotrimeric DNA-PK.  30-
mer double-strand DNA was also added where indicated, as it has been reported that 
Artemis exhibits increased endonuclease activity when double-strand DNA is 
incubated in the reaction so as to increase kinase activity of DNA-PK, thus increasing 
phosphorylation of Artemis.  Previous groups have shown that DNA-PK dependent 
Artemis endonuclease cleavage of this hairpin substrate yields a product of 
approximately 28 bases in length [74].  Both the Ni pool and HAP FT pools of 
protein catalyzed hairpin-opening activity in the presence of ATP and DNA-PK on 
this substrate (Figure 27B, lanes 6 and 7 and lanes 10 and 11, respectively).  
Interestingly, there is slightly more endonuclease activity in the HAP FT pool of 
protein, as evidenced by the slightly more prominent cleavage product (Figure 27B, 
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lanes 10 and 11).  It is important to point out that this could be from the lack of 
exonuclease activity in the HAP FT, which would necessarily result in less 
endonucleolytic removal of the 5’ label on the cleavage product thus creating a darker 
band at this product size.  Interestingly, the presence of the 30-mer cold double-strand 
substrate does not seem to result in increased cleavage product with this substrate 
(Figure 27B, lane 8), and this result will be discussed further in conclusion.  Also 
evident, though of reduced intensity compared to the hairpin opening activity, are 
products that range in size from 5-7 nucleotides and are postulated to result from the 
5’ overhang cleavage activity of Artemis.  Importantly, the 5’ dNMP product 
produced by exonuclease activity cleaving the 5’ label on the hairpin substrate is 
evident in reactions performed with the nickel pool, but is substantially reduced in 
reactions performed using the HAP flow-through fractions.  This result is clearer 
following reduced exposure of the gel to minimize bleed-over from the Ni pool 
fractions (Figure 27B, bottom panel).  These results show that separation of 
exonuclease activity from DNA-PK dependent Artemis endonuclease activity occurs 
following fractionation over a HAP column. 
We were concerned that the radiolabeled products from a substrate containing 
a 5’ radioactive label observed in Figure 27A were potentially being misinterpreted.  
Despite experimental precautions taken, it was difficult to determine if the 
radiolabeled product at the bottom of the gel (Figure 27A) was actually a dNMP or a 
larger product.  To ensure that the dNMP products observed (from the Ni pool) were 
in fact the result of exonuclease activity and not a dinucleotide product produced by 
an endonuclease activity, we assessed nuclease activity of each pool of protein on a  
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Figure 27.  Biochemical characterization of Nickel-Agarose and HAP flow-
through pools of [His]6-Artemis. (A) Analysis of [His]6-Artemis Ni pool and HAP 
FT exonuclease activity on 30 base 5’ radiolabed single-strand DNA.  Increasing 
amounts of Ni pool (100 ng to 1 µg) or HAP FT (5 ng to 50 ng) pool was assayed for 
exonuclease activity using 50 fmol of 5’ [32P] single-strand DNA substrate as 
described in Materials and Methods.  (B) Analysis of hairpin opening activity.  Ni 
pool (400 ng and 1 µg) or HAP FT (20 ng and 50 ng) was incubated with 250 fmol of 
5’ radiolabeled hairpin DNA substrate, 200 nM double-strand cold DNA (30-mer), 
and 50 nM of DNA-PK as indicated.  Following endonuclease cleavage, reaction 
products were separated and visualized as described in Materials and Methods.   
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single-strand DNA substrate with a 3’ radiolabeled terminus.  Increasing amounts of 
the nickel pool of protein resulted in a ladder of products that was consistent with 
sequential single nucleoside monophosphate removal from the 5’ terminus of the 
oligonucleotide (Figure 28A).  The HAP FT pool of protein contained barely 
detectable 5’-3’ single-strand exonuclease activity, consistent with activity seen in 
this pool in Figure 27A.  Importantly, overexposure of the gels in Figures 27A and 
28A did reveal products indicative of low levels of exonuclease activity, but this 
activity comprised less than 1 % of those seen in Ni pool.  These results confirm that 
while [His]6-Artemis fractionated over a nickel column retains significant 5’-3’ 
exonuclease activity, subsequent fractionation of this protein over a HAP column 
results in near quantitative separation of the exonuclease from the Artemis protein. 
 As it appears that [His]6-Artemis fractionated over a HAP column is devoid of 
5’-3’ exonuclease activity but still has hairpin opening activity, we wanted to 
examine DNA-PK dependent Artemis overhang cleavage activity to ensure that all in 
vivo intrinsic enzymatic activities are retained in this purified preparation of protein.  
To accomplish this, we prepared a 5’-radiolabeled DNA substrate with a 3’ single-
strand overhang.  It has been previously reported that in the presence of DNA-PK and 
ATP, Artemis cleaves this substrate close to the single-strand/double-strand junction, 
resulting in a cleavage product around 26 bases long [74].  Incubation of this 
overhang substrate with DNA-PK, ATP and the two pools of [His6-Artemis] protein 
resulted in a 26 base cleavage product, and as expected this was dependent on DNA-
PK and ATP (Figure 28B, lanes 4, 5 and 6 and lanes 8, 9 and 10).  Again, the 5’ NMP 
product is apparent in reactions performed with the nickel pool of protein but is  
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Figure 28.  Characterization of Artemis nuclease activity. (A) Analysis of Ni pool 
and HAP FT exonuclease activity on single-strand DNA with a 3’ 32P label.  Assays 
were conducted as described in the legend to figure 4B), except the single-strand 
oligonucleotide was radiolabeled by incorporation of [α-32P] on the 3’ termini.  (B) 
Analysis of endonuclease activity on a 5’ radiolabeled DNA substrate with a 3’ 
single-strand overhang.  Reactions were conducted as described in 4C, except Ni 
pool, HAP FT, 250 µM of ATP and 200 nM of cold duplex DNA (30-mer) were 
added as indicated.   (C) Analysis of endonuclease activity on a 3’ radiolabeled DNA 
substrate with a 5’ single-strand overhang.  Reaction conditions were conducted as 
described in “Methods and Materials”.  Each DNA substrate is depicted above the gel 
and the position of the [32P] label is denoted by the asterisk and the position of 
Artemis endonuclease activity is denoted by the carat.  DNA strand lengths of each 
DNA substrate are also noted in the figure.  The 5’ nucleoside monophosphate 
product (5’ dNMP) is indicated by the arrows in panel B. 
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reduced to background levels in reactions containing the HAP flow-through pool 
(Figure 28B, compare lanes 3-6 to lanes 7-10).  For further verification of 
endonuclease activity, a DNA substrate with a 5’ single-strand overhang and a 3’ [α-
32P] dCMP label was used to assay endonuclease activity on a 5’ overhang.  Previous 
results have shown that in the presence of DNA-PK and ATP, Artemis 
endonucleolytically cleaves this substrate close to the single-strand/double-strand 
junction resulting in a cleavage product of approximately 24-26 nucleotides long 
(lees-miller paper).  In the presence of DNA-PK and ATP, both the nickel pool of 
protein and the HAP FT pool endonucleolytically cleaved the 5’ overhang (Figure 
28C, compare lanes 5 and 6 and lanes 7 and 8, respectively).  In our hands, the 
resulting cleavage product is 26 nucleotides.   A product that is consistent with 
exonuclease activity appears at the bottom of the gel, but only appears in lanes that 
contain DNA-PK in them, including but not limited to the lane that contains DNA-PK 
alone (Figure 28C, lane 4), this product is attributed to a contaminating 3’ 
exonuclease from our preparation of DNA-PK from Hela cells.  The combined data 
from Figures 27 and 28 demonstrate that both the Ni and HAP FT pools of protein 
maintain DNA-PK and ATP dependent hairpin opening and endonuclease activity on 
single-strand overhangs, identical to the activity previously reported on Artemis.  
However, while the Artemis polypeptide is in both these pools of protein (Figure 
26A), the HAP FT pool of protein no longer exhibits single-strand exonuclease 
activity despite the fact that it retains DNA-PK dependent endonuclease activity.  
These results show that our purification procedure results in biochemical separation 
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of exonuclease activity from Artemis, and further suggest that the exonuclease 
activity previously attributed to Artemis is not an intrinsic part of the polypeptide. 
 In an effort to thoroughly ensure that we separated exonuclease activity away 
from Artemis, exonuclease and endonuclease activities were tracked throughout the 
HAP column, 100 % of the endonuclease activity is recovered in the HAP FT pool, 
resulting in a 30-fold level of purification (Table 2).  However, only 2.5 % of the 
exonuclease activity is retained in the same HAP FT pool, with no increase in specific 
activity despite the loss of 96 % of the total protein.  These results are consistent with 
successful biochemical separation of the exonuclease activity from the Artemis 
polypeptide while maintaining DNA-PK dependent endonuclease activity, thereby 
indicating that exonuclease activity is not an intrinsic component of the Artemis 
polypeptide.   
 Having obtained a preparation of Artemis that we believe to be more 
enzymatically pure than any other lab has previously obtained, we were anxious to 
pursue further experiments to assess the role of DNA-PK dependent Artemis 
catalyzed nuclease activity on a variety of DNA substrates containing different 
structures, sequences and regions of microhomology.  The substrates used in 
endonuclease assays discussed above were all previously published substrates and so 
activity of Artemis on these substrates has been characterized.  Unfortunately, these 
substrates are not necessarily reminiscent of a DNA termini at the site of an IR 
induced DNA DSB.  A DNA substrate physiologically mimicking IR induced DSB is 
anticipated to have a much shorter DNA overhang.  As a substrate with shorter 
overhangs has not been studies by any other lab, we assessed more physiologically  
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Table 2.  Purification table of [His]6-Artemis protein preparation. 
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relevant DNA substrates with 6-base single-strand overhangs.  In an effort to measure 
endonuclease activity on a DNA substrate that more closely resembles a DNA 
terminus following IR, we assessed cleavage of a 24-base double-strand substrate 
with a 6-base 5’ single-strand overhang and a 3’ [α-32P] dCMP label (KSP 11.3/5’30).  
In an effort to avoid any sequence bias that might exist, the single-strand overhang 
region is made up of a mixed nucleotide sequence.  Results show that in the presence 
of DNA-PK and ATP, Artemis cleaves this substrate at the double-strand/single-
strand junction to create a product of 24 bases (Figure 29, lane 4).  This is evidence 
that Artemis is capable of cleaving shorter DNA overhangs like the types of 
overhangs one would expect to see at the site of an IR induced DNA DSB.  We went 
on to asses two additional DNA substrates that were identical to the substrates in 
Figure 29 except with homopolymeric overhangs, one with a 6-base 5’A overhang 
(KSP 11.3/5’24+6A) and one with 6-base 5’T (KSP 11.3/5’24+6T) (Figure 30).  
Again, Artemis was able to efficiently cleave the 6-base overhang on these two 
substrates, but the cleavage product was not as homogeneous as the product observed 
in Figure 29, where the predominant cleavage product was 24 bases long.  In Figure 
30, cleavage products are more heterogeneous, with cleavage products that vary 
between 23 and 25.  While it appears that Artemis can still cleave these two substrates 
at the double-strand/single-strand junction (24 bases), cleavage is also occurring at 
n+1 and n-1 positions.  As the only difference between these two substrates and the 
one assessed in Figure 29 is sequence, it is presumed that this difference in cleavage 
pattern is a result of a sequence bias.  Furthermore, there appears to be greater 
cleavage of the DNA substrate with a 5’ T overhang (Figure 30, lanes 2 and 13). 
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Figure 29.  Characterization of Artemis endonuclease activity on a short DNA 
overhang substrate.  Artemis endonuclease cleavage of 3’ radiolabeled 6-base 5’ 
single-strand overhang with a 24 basepair region was analyzed.  Reaction conditions 
were conducted as described in “Methods and Materials”.  The DNA substrate is 
depicted above the gel and the position of the [32P] label is denoted by the asterisk 
and the position of Artemis endonuclease activity is denoted by the arrow.  
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Figure 30.  Characterization of Artemis sequence bias on short DNA overhang 
substrates.  Artemis endonuclease cleavage of 3’ radiolabeled 6-base single-strand 
overhang of 5’ A or 5’T was analyzed.  Reaction conditions were conducted as 
described in “Methods and Materials”.  The DNA substrates are depicted above the 
gel and the position of the [32P] label is denoted by the asterisk and the position of 
Artemis endonuclease activity is denoted by the bracket. 
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In order to further explore Artemis sequence bias, DNA substrates with 
homopolymeric sequences of A or T in a 15-base 5’ single-strand overhang region 
were analyzed (KSP 11.1/11.0C and KSP 11.2/11.0C).  While both substrates were 
cleaved by Artemis, results clearly show a cleavage sequence bias, with 5’T 
substrates preferentially cleaved compared to 5’A (Figure 31).  This is supported by 
recent data showing that Artemis possesses DNA-PK dependent endonuclease 
activity on single-strand DNA, with a sequence preference favoring cleavage of 
thymidines [108].  In summary, analysis of Artemis mediated cleavage reveals that 
this nuclease is capable of cleaving much shorter overhang regions than those 
previously published, and both the cleavage activity and pattern of cleavage is 
affected by length and sequence.  Further studies with DNA substrates of different 
length and sequence will reveal the intricacies of Artemis cleavage and potentially 
indicate a mechanism of Artemis-DNA interaction. 
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Figure 31.  Characterization of Artemis sequence bias on long DNA overhang 
substrates.  Artemis endonuclease cleavage of 3’ radiolabeled 15-base single-strand 
overhang of 5’ A or 5’T was analyzed.  Reaction conditions were conducted as 
described in “Methods and Materials”.  The DNA substrates is depicted above the gel 
and the position of the [32P] label is denoted by the asterisk and the position of 
Artemis endonuclease activity is denoted by the bracket. 
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 Our design and implementation of a novel purification procedure of [His]6-
Artemis resulted in the biochemical separation of exonuclease activity from DNA-PK 
dependent endonuclease activity.  Interestingly, other laboratories have made 
mutations in various positions throughout the Artemis polypeptide in an effort to 
identify the nuclease active site.  Some of these mutations have resulted in disruption 
of the endonuclease activity but have had no effect on exonuclease activity [73, 103, 
106, 113, 116, 117].  For example, N-terminal Artemis mutations located in the 
enzymatically important metallo-β-lactamase and β-CASP domains resulted in 
identification of a sub-set of mutants that functionally abrogated endonuclease 
activity by disrupting metal coordination [113].  Importantly, biochemical analysis of 
these mutants resulted in no loss of exonuclease activity.  Additional work with a 
phosphorylation mutant that is associated with partial immunodeficiency in a mouse 
model exhibited reduced endonucleasee activity but nearly complete retention of 
exonuclease activity [118].  It is possible that the exonuclease activity could be 
located in another active site other than those identified by the extensive set of mutant 
generated.  However, this seems unlikely as it is thought that metallo-β-lactamse fold 
enzymes have one active site that is responsible for all enzymatic processing [114].  
This hypothesis is further supported by data published on SNM1, a 5’-3’mammalian 
exonuclease classified in the metallo-β-lactamase superfamily.  SNM1 is 
characterized by having only exonuclease activity on single-strand DNA, with no 
accompanying endonuclease activity.  A mutation of a conserved aspartate (D736) in 
the β-lactamase domain resulted in functional disruption of the 5’-3’ exonuclease 
4.3.  Discussion 
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activity [117, 119].  Another group had made a mutation of this same conserved 
aspartate residue in Artemis (D37) that completely eliminated endonuclease activity 
of Artemis, but the exonuclease activity associated with Artemis remained in the 
mutant [113].  This is genetic evidence to further support our biochemical evidence 
indicating that the exonuclease activity is not located in the same active site as the 
endonuclease activity.  Importantly, the extensive Atremis mutational analysis done 
to date has yet to locate an exonuclease active site within Artemis.  These genetic 
studies coupled with our biochemical analysis indicate that not only is the 
exonuclease activity separate from the endonucleolytic active site, but it is not part of 
the Artemis polypeptide at all.   
 The purification scheme presented in this chapter was developed and then 
executed over multiple protein purification preparations.  While every successful 
preparation resulted in separation of the two nuclease activities as described, it is 
important to point out that separation of the activities did vary between protein 
preparations.  As development of the purification procedure progressed, variations in 
procedure would at times result in small changes in the separation of the exonuclease 
activity from the Artemis endonuclease activity.  For example, we found that greater 
separation of activity was achieved on a 5 mL HAP column compared to a 2 mL HAP 
column, despite the fact that the 2 mL column contained more than enough binding 
capacity for the protein amount that we applied to the column.  Importantly, the 
residual exonuclease activity that flowed through the 2 mL HAP column (and thus 
contaminated our Artemis pool of protein that also flowed through the column) could 
be successfully separated by re-running the FT pool over a second HAP column.  
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This was an interesting finding, as it suggests that the 2 mL HAP column could 
become saturated with exonuclease activity and lead to poor separation of the 
exonuclease and endonuclease activity.  We also noticed variations in separation 
when the pH of buffers used for the HAP column was altered with lower pH resulting 
in poorer separation of the exonuclease activity, so our buffers contain a relatively pH  
of 7.85.  Typically binding to a HAP column is performed at a lower pH as the lower 
the pH, the more protein binds to the matrix.  [His]6-Artemis does not bind to the 
HAP column and this is likely the result of the higher pH buffer.  Many other proteins 
do not bind to the HAP column under these conditions as well, as evidenced by the 
amount of non-specific proteins in the HAP FT (Figure 21C).  Interestingly, the 
exonuclease activity remains bound to the column under these conditions.  It is also 
important to point out that we observed a nominal amount of Artemis in many of the 
fractions collected from the HAP column, including the wash and elution (Figure 21B 
and data not shown).  These levels of protein were low enough that they could only 
be observed by western blot analysis, and even then the signal was very low.  This 
phenomenon was also observed during fractionation over the nickel-agarose column, 
indicating a certain degree of spreading of the fusion protein during all fractionation 
steps.  Interestingly, spreading of the protein was also seen over other columns (ie. 
ion exchange), leading us to conclude that this protein has propensity for multiple 
matrices.  This could also explain the fairly high amount of non-specific proteins that 
we see eluting with Artemis off of different columns.  In short, Artemis may be a very 
“sticky” protein, perhaps due to one or several disordered regions, that gives it an 
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affinity for multiple matrices as well as attracts a variety of protein-protein 
interactions.   
 Our study demonstrates that the exonuclease activity of Artemis previously 
reported is not an intrinsic component of the Artemis polypeptide, and there are many 
possibilities to explain the presence of the exonuclease activity found in less-pure 
fractions of Artemis.  It is possible that the exonuclease activity is simply a 
contaminating enzyme that is endogenously expressed in the SF9 insect cells we use 
to overexpress Artemis and co-purifies with over-expressed Artemis independent of 
any biologically relevant interaction.  This possibility is supported by our 
observations of Artemis being a “sticky” protein with an affinity for non-specific 
interactions.  It is further supported by our data showing single-strand 5’-3’ 
exonuclease activity co-purifying with another DNA binding protein, [His]6-XPA, 
overexpressed in insect cells.  This result suggests the possibility of the contaminating 
exonuclease having an affinity for nickel-agarose resin, as both the XPA and Artemis 
preparations were fractionated over this column first.  This is not an unlikely 
scenario, as insect cells have been shown to contain many endogenous nucleases and 
the 5’-3’ exonuclease SNM1 was also identified in D. Melanogaster [120].  It is also 
possible that the exonuclease is another enzyme that is associated with Artemis and 
plays a physiological role with Artemis in the cell.  This possibility will have to be 
further investigated.   
 Our purification scheme resulted in a preparation of Artemis that is devoid of 
exonuclease activity that was previously thought to be intrinsic to Artemis but 
maintains the biologically relevant DNA-PK and ATP dependent endonuclease 
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activity.  With this preparation of Artemis, we began to conduct experiments to 
further understand the role of this endonuclease activity in NHEJ.  Our studies with 
more biologically relevant substrates containing shorter overhang regions have shown 
that Artemis is capable of cleaving shorter overhang regions.  Furthermore, a 
sequence bias is observed, with Artemis preferentially cleaving DNA substrates with 
5’ T overhangs as compared to 5’ A overhangs.  The explanation for sequence bias 
could be as simple as thymine fitting into the Artemis active site better than other 
bases.  Support for this hypothesis is seen in Figure 29, where a cleavage 
predominantly occurs at the double-strand junction.  This substrate has an overhang 
made up of a mixed 6-base substrate consisting of G, C and A in the overhang region, 
with a T as the first nucleotide in the double-strand region (TGCCGAA).  This data 
suggests that Artemis preferentially cleaves thymines, and as the resulting cleavage 
product is 24 bases long (with the 6-base single-strand overhang endonucleolytically 
cleaved off), this cleavage would have to occur on the 5’ end of the nucleotide.  
Interestingly, sequence bias appears to be more important when a DNA overhang is 
longer as the difference in Artemis cleavage between 5’T and 5’A 15-base overhangs 
is much more pronounced than the difference in 5’T and 5’A 6-base overhang 
cleavage, but the relevance of these results is still unclear.  Additional biochemical 
studies with DNA substrates needs to be done to understand how sequence bias and 
strand length affect DNA-PK and ATP dependent Artemis-catalyzed cleavage.  
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5.  Summary and Perspectives 
NHEJ, the major pathway responsible for the repair of DNA DSB, was 
originally defined as a simple pathway that crudely joined DNA DSB with the help of 
a handful of proteins, Ku, DNA-PKcs, and Ligase IV/XRCC4.  Extensive research in 
the field over the years has changed our view of NHEJ, and it is now apparent that 
this is a complex and intricate pathway that includes a variety of other proteins 
including processing enzymes Artemis, DNA polymerases µ and λ and the Ligase IV 
associated protein XLF.  Biochemical and structural analysis has resulted in fairly 
detailed characterization of many of these proteins.  However, many unanswered 
questions regarding molecular mechanism of these proteins remain.   
Our work has further characterized the largest enzyme in this pathway, DNA-
PK, and results suggest a model for activation of DNA-PK.  In our proposed model, 
DNA threads through a channel in DNA-PKcs following binding of this large kinase 
to a DSB (Figure 32A).  Strand separation of the DNA terminus likely occurs, with 
the 5’ strand being inserted into an active site on the periphery of the kinase and the 
3’ strand potentially annealing with a 3’ strand on the opposite DNA terminus.  This 
3’ strand-dependent interaction may be responsible for further pulling the DNA 
through the kinase structure, and thus increasing overall kinase activity.  This DNA 
strand interaction may also play a role in stabilizing a synaptic complex of the two 
DNA termini-protein complexes.  Elegant work has shown that DNA-PK 
autophosphorylation occurs in a trans fashion [82], however this does not necessarily 
mean that the protein-DNA interaction that drives activation occurs in a trans fashion.  
Activation of the kinase by the 5’ strand could occur in either a cis or trans fashion  
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Figure 32.  DNA-PK activation and Artemis-mediated cleavage.  (A) DNA 
threads through the ring-like structure of the Ku heterodimer (blue doughnut 
structure) and through a channel in DNA-PKcs (yellow structure).  Following 
threading of the DNA, strand separation occurs and the 3’ strand (depicted in green) 
drives homology-mediated interactions with the opposite 3’ strand, aiding in 
formation of a synaptic complex between the two DNA termini.  The purple shadow 
indicates the magnification of the region in figure 4B and 4C.  (B) Cis activation of 
DNA-PK (yellow structure) occurs by the 5’ strand (depicted in blue) interacting with 
an active site that can accommodate single-strand DNA on the periphery of the same 
DNA-PK molecule that is bound to the DNA terminus.  Artemis (orange structure) 
interacts with DNA-PK and cleaves DNA in a trans fashion by cleaving a single-
strand overhang on the opposite DNA terminus.  (C) Trans activation occurs by 5’ 
single-strand DNA interacting with the active on the DNA-PK molecule bound to the 
opposite DNA terminus.  Artemis interacts with DNA-PK and cleaves DNA in a cis 
fashion by cleaving a single-strand overhang on the same terminus with which DNA-
PK and Artemis are interacting.  
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(Figure 32B and C).  Further studies are needed to determine DNA-mediated 
activation of the kinase.   
Biochemical and structural work has shown that trans autophosphorylation of 
the ABCDE cluster allows for rearrangement of the protein-DNA complex such that 
the DNA ends are made accessible for processing enzymes [63].  
Autophosphorylation induced conformational changes appear to occur mainly in the 
head domain of DNA-PKcs.  This is the region where the kinase domain is thought to 
be located, and it is possible that conformational changes could result in generation of 
a platform for enzymes to engage in processing of the DNA termini.  This model 
suggests that DNA-PK is responsible for holding DNA termini in place while 
processing of the ends occurs.  This is an interesting idea, as it suggests that DNA-PK 
remains bound to DNA while processing occurs.  Previous models have suggested 
that dissociation of DNA-PK is occurs following autophosphorylation.  However, in 
the model described above, autophosphorylation of one cluster of residues has already 
occurred in order to leave DNA ends accessible for processing but dissociation of 
DNA-PK has not yet occurred.  Therefore, this suggests that a second round of DNA-
PK autophosphorylation that results in dissociation of the kinase may occur following 
DNA end processing.  It is very possible that a different set of residues (other than the 
ABCDE cluster) must be phosphorylated to initiate DNA-PK dissociation from the 
termini.  Further studies are needed to determine the mechanisms and dynamics of 
DNA end processing and DNA-PK dissociation. 
Biochemical studies of Artemis to date clearly indicate that more research is 
necessary to fully understand the molecular mechanism of DNA-PK and Artemis-
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mediated DNA cleavage in NHEJ.  Combined results from the field suggest a model 
for DNA-PK and Artemis interactions with DNA ends.  DNA strand polarity clearly 
plays a role, as 3’ and 5’ cleavage of single-strand overhangs varies slightly, with a 3’ 
overhang getting cleaved to within 4 nt of the double-strand junction while 5’ 
overhangs are cleaved predominantly at the double-strand junction with minor 
cleavage events at n+1, n-1 [74, 106].  Our lab and others have also shown that a 3’ 
overhang results in a more heterogeneous cleavage set, with the n+4  position being 
cleaved more predominantly but additional cleavage of surrounding nucleotides, up to 
two in either direction, occurs as well.  This differs from the homogenous cleavage 
pattern of a 5’ overhang resulting in predominant cleavage at the double strand 
junction.  It is possible that this variation is a product of DNA positioning as driven 
by DNA-DNA-PK interactions.  Our data demonstrates that 5’ overhangs may be 
crucial for activation and thus may possess more well defined interactions with the 
DNA-PKcs subunit, which could create a uniform alteration in the DNA structure to 
allow more precise cleavage by Artemis at the single-strand/double-strand junction 
(Figure 33A).  3’ overhangs do not necessarily have such a defined interaction with 
DNA-PKcs, as Artemis is forced to interact with DNA overhangs in a stochastic 
manner, creating a more random cleavage pattern that results in cleavage products of 
assorted sizes (Figure 33B).  Further work analyzing DNA substrate length, structure 
and sequence will result in an increased understanding of the molecular mechanism of 
Artemis and its overall role in NHEJ. 
 Despite the biochemical data gathered, many questions remain regarding 
DNA-PK dependent Artemis endonuclease activity.  It is clear that Artemis requires  
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Figure 33.  Artemis endonuclease activity on single-strand overhangs.  DNA-PK 
dependent Artemis-mediated cleavage of overhangs varies based on strand polarity.  
Ku heterodimer is depicted in blue, DNA-PKcs is depicted in yellow, and Artemis is 
depicted in orange.  (A) Artemis cleaves 3’ overhangs in a heterogenous manner, with 
cleavage products occurring at the n+6, n+5, n+4, n+3 and n+2 positions.  All of 
these potential cleavage products result in a 3’ overhang remaining at the DNA 
terminus.  (B) Artemis cleaves 5’ overhangs in a homogeneous, with cleavage mainly 
occurring at the single-strand/double-strand junction and a few cleavage events 
occurring at the n+1 or n-1 positions.   
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DNA-PK and ATP for endonuclease activity, but it is unclear if this activation by 
DNA-PK is through a cis or trans mechanism.  Several labs have performed in vitro 
nuclease assays with a radiolabeled overhang substrate, but include unlabeled double-
strand DNA to increase DNA-PK activity, arguing that this increases the 
endonuclease activity of Artemis.  However, it is hard to imagine an in vivo scenario 
at the site of a DSB where DNA-PK is acting in trans to activate Artemis (Figure 34).  
In fact, work by Povirk’s group has shown that Artemis nuclease activity is not 
increased in the presence of a dsDNA stimulus [99], and Lees-Miller group observes 
robust endonuclease stimulation in the absence of stimulating dsDNA [106].  Rather, 
an alternative is that DNA-PK is bound to the site of a DSB, Artemis is recruited to 
this same DNA end and Artemis is activated in cis by this DNA-PK molecule.  Once 
DNA-PK dependent Artemis-catalyzed endonuclease cleavage is activated, cleavage 
events could occur through a cis or trans mechanism.  The DNA/DNA-PK/Artemis 
complex described could be envisioned to stimulate trans endonucleolytic cleavage.  
That is, just as trans autophosphorylation of DNA-PK occurs, Artemis too could be 
bound to one terminus in a complex with DNA-PK and act catalytically across the 
synaptic complex to cleave DNA on the opposite terminus (Figure 32B).  As a DNA 
DSB induced by IR can be very complex, with a variety of DNA discontinuities on 
either terminus at the site of the DSB, it is possible that Artemis cleaves a DNA 
terminus in trans that needs to be processed, even if the side it is bound to does not 
require processing.  It is also possible that Artemis cleaves a DNA strand in cis 
(Figure 32C), similar to DNA-PK being activated in cis. 
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Figure 34.  Activation of Artemis endonuclease activity.  Artemis endonuclease 
activity is dependent on DNA-PK and ATP, and this activation event could occur in 
trans by a DNA-PK molecule bound to a different DNA terminus than the terminus 
Artemis is cleaving.  Activation of Artemis endonuclease activity could also occur in 
cis by a DNA-PK molecule that is bound to the same DNA terminus that Artemis is 
cleaving (see Figure 33). 
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It is becoming increasingly clear that processing during NHEJ is an important 
yet complicated step that requires regulation at the molecular level.   In the context of 
a DNA DSB induced by IR, a small amount of processing can be extremely useful.  It 
is becoming more apparent that regions of microhomology, embedded within the 
DNA sequence in the vicinity of a double strand break, may play a role in successful 
re-joining of broken DNA (see Chapter 3).  Artemis-catalyzed nuclease activity to 
excise nucleotides, revealing regions of microhomology may be a critical step in 
NHEJ.   Processing of DNA termini to remove forms of DNA damage (like 3’ 
phosphoglycolates or abasic sites) that would otherwise impede DNA ligation of the 
DSB or cause further harm to the cell is another example of useful DNA processing 
during NHEJ.  This “micro” type of processing is less detrimental than massive 
processing that would result in depletion of a large amount of genetic material.  
Furthermore, it is more energetically favorable for the cell to have mechanisms in 
place to remove DNA damage while repairing the DNA DSB.  The opposite scenario 
would result in DNA damage, such as an abasic site, persisting in the DNA and 
having to be removed via another repair process after resolving the DSB.  It is 
important to point out that this minimal amount of processing described, while 
favorable for the cell probably requires a variety of enzymes to accomplish specific 
processing events like synthesis or degradation of DNA ends to get to a region of 
microhomology or to remove/repair other types of DNA damage around the terminus 
with minimal loss of nucleotides.  Elaborate processing events are important in the 
context of repair of IR induced DNA DSB, as IR can result in a variety of DNA 
damage at the site of a break that would need to be removed for efficient and effective 
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NHEJ.  As these breaks can be so complex, it is likely that there are several enzymes 
involved in the processing steps of NHEJ that have yet to be identified. 
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